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scope of the Thesis 
The postulated model for the insulin - stimulated induction 
of mRNA efflux (Purrello et al., 1983) is based on the 
demonstrated binding of insulin to intracellular membrane 
structures (see chapter 2, section 2.2.1), and the in vitro 
effect of insulin on nuclear envelope phosphorylation, 
NTPase activity, and mRNA efflux (see chapter 5, section 
5.1). These independent observations have led to the 
development of a model for the direct induction by insulin, 
at the level of the nucleus, of mRNA efflux (figure I.1). 
However, the specific intracellular insulin binding has been 
inf erred from kinetic or morphological studies which have 
not identified a discrete membrane - bound polypeptide(s) as 
an insulin docking molecule in situ (Goldfine, 1981). Also, 
the stimulation of NTPase activity has only been established 
by monitoring the level of general ATP hydrolysis of nuclear 
envelope fractions in the presence and absence of insulin 
(Purrello et al., 1983). 
The scope of this thesis has been to further the 
understanding of this mechanism by attempting to a) 
unequivocally identify a specific nuclear envelope -
associated insulin docking polypeptide in situ and b) to 
demonstrate that insulin directly affects the ATP - binding 
of nuclear envelope ATP - binding proteins. The latter would 
demonstrate a primary effect of insulin i.e. the modulation 
of the ATP - binding capacity of identified NTPases / 
protein kinases (or their release from some inactive storage 
form), and not a general phenomenon such as elevated ATP -
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Figure ·I .:1 The· Proposed Mechanism for Insulin - Induced mRNA 
Efflux from the Nucleus (Purrello et al., 1983). 
Insulin binding tb a putative specific' nuclea·r envelope 
receptor ·resUl t·s in a genet:!al stimulation of phosphatase 
activity. One of the targets of this increased phosphatase 
activity is the inactive phosphorylated NTPase, which upon 
dephosphorylation, has an increased affinity for both ATP 
and mRNA. The consequence of this is the increase in both 
mRNA nucleocytoplasmic translocation and ATP hydrolysis. 
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Chapter 1 
The synthesis of carrier - Free [12SI]SASD - Derivatised 
Insulin and its Use in Identifying Putative Intracellular 
Insulin Receptors. 
1.1 The Synthesis of Carrier - Free [12SI]ASD-Insulin 
1.1.1 Introduction 
Insulin has been reported to have direct effects at the 
level of the nucleus {see 4.1) and evidence has been 
published for specific insulin binding to isolated nuclei 
(see 1.2.1). These in vitro binding studies are corroborated 
by in situ results demonstrating the internalisation of 
insulin {see 1.2.1). 
' Wong et al. {1988) .have isolated and characterised an 
insulin binding protein from nuclei but it would be of 
interest to demonstrate specific insulin binding to 
protein(s) in intact intracellular components. Such a 
demonstration would corroborate previous findings that 
insulin has a direct effect on nuclear activity. This 
chapter describes the strategy employed to .probe for 
putative insulin receptors in vitro and in sit~. Briefly, a 
carrier - free, radioactive, photoactivatable insulin 
derivative was syn~hesised and characterised for both 
integrity and biological activity {l.1.2). This derivative 
was then used to probe for insulin docking proteins (l.2.2). 
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Figure 1.1.1 The Molecular structure of some 
Photoactivatable Heterobifunctional Reaqents. 
{3) 
These examples illustrate the general structural 
characteristics of photoactivatable heterobifunctional 
reagents. Most consist of a photoactivatable phenyl azide 
moiety which is iodinatable at the meta position in the case 
of SASD (3) and a hydroxysuccinimide ester moiety for the 
coupling to an appropriate ligand. The length of the linker 
arm can be varied and may contain a cleavable disulfide bond 
as depicted in (2) and (3). 
1) NHS-ASA (N-hydroxysuccinimide ester of 4-azidosalicylic 
acid. · 
2) NHS-AFDP (N-hydroxysuccinimide ester of 3-((4-
azidophenyl)dithio)propionimidate. 
3)SASD, (sulfosuccinimidyl 2-(p-azidosalicylamido)ethyl-1 1 3-
dithiopropionate. 
2 
1.1.1.1 Photoactivatable Heterobifunctional Reagents 
Recently, considerable development of photoactivatable 
heterobifunctional derivatives to investigate protein -
protein interactions has taken place {Vanin & Ji, 1981; Ji & 
Ji, 1982; Jaffe et al., 1980; Knutson, 1987; Lowndes et al., 
1988) . 
The reagents consist of a hydroxysuccinimide ester moeity 
and an iodinatable phenyl azide group {figure 2.1.1) which 
is photoactivatable. The resultant nitrene reacts to form a 
covalent bond with a neighbouring protein. The great 
advantage of these reagents is that they are chemically 
inert until photoactivated, thus allowing considerable 
freedom in the design of experiments. Thus, by coupling the 
reagent to a ligand via the hydroxysuccinimide ester, it is 
possible to identify molecules with which the ligand is 
interacting by simply photoactivating the azido moeity. The 
resultant activated nitrene then reacts with the molecule, 
thus covalently crosslinking the interacting molecules. 
Of special interest is the use of iodinatable, cleavable 
reagents such as SASD (sulfosuccinimidyl 2-{p-
azidosalicylamido)ethyl-1,3 '-dithiopropionate), which after 
crosslinking the ligand to its relevant counterpart, can be 
cleaved by the addition of a reducing agent. This results in 
the dissociation of the ligand and the radioactive tagging 
of the interacting molecule. This has proved to be 
invaluable in the study of subunit - subunit and ligand -
receptor interactions. 
Amongst other uses these reagents have been employed to 
label glycopeptides {Ji, l977; Shephard et al., 1988); to 
study ribosomal subunit interactions (Maassen, 1979); to 
localise and identify prostaglandin and toxin receptors 
(Kattelman et al., 1987; Lima et al., 1988); and to study 
the identity, localisation, and internalisation of peptide 
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Fi~ure 1.1.2 Protocol for the Synthesis of Carrier - Free 
[l SI)ASD-Insulin. 
4 
NH2 
hormone and neuronal receptors (Horowitz et al., 1988; 
Kramer et al., 1988; Nikolics et al., 1988; Niznik et al., 
1988; Ricard et al., 1988; Whiting & Lindstrom, 1987). 
Of special interest is the use of these reagents to 
investigate the identity and internalisation of the insulin 
receptor (Podlecki et al., 1987; Hofmann et al., 1981; Yip 
et al., 1980; Knutson, 1987). 
1.1.1.2 The Derivatisation of Insulin with SASD 
There are a number of important considerations when 
synthesising a photoactivatable insulin derivative: 
1) The insulin should be derivatised in such a way as to 
limit the loss of biological activity either as a result of 
perturbing the tertiary structure of the hormone or by 
modifications of essential amino acid side chains during 
derivatisation. 
2) Radiolabelling of the derivatised insulin should be on 
the reagent only and not the insulin molecule itself. 
3) The derivatised insulin should be of the maximum specific 
activity i.e. preferably carrier - free so that even low 
abundance receptors may be detected. 
4} The derivatised insulin preparation should be free of any 
uncoupled radioactive reagent which would indiscriminately 
label upon photolysis. 
The protocol adopted for the synthesis of carrier - free 
[125I]ASD-insulin is illustrated in figure 1.1.2 and was 
based on the above - mentioned considerations. 
The photoreactive reagent SASD was chosen to derivatise 
insulin because it is iodinatable and cleavable, ideal 
5 
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Figure 1,1,3 HPLC Separation of Boced-Insulin Products 
Insulin was derivatised with BOPA as described in 6.2.2 and 
the products subjected to HPLC. 
Peaks l and 2 were collected, lyophilised and subjected to 
acid-urea PAGE for positive identification (inset) 
Inset: The lanes l and 2 represent peaks l and 2 
respectively. The standards lane consists of diboc-insulin 
(DJ and triboc-insulin (T). 
* denotes the pos,tion at which insulin elutes. 
6 
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properties to probe for insuli'n receptors. 
It was considered esse~tial that the photoaff inity moiety be 
iodinated prior to coupling to insulin. If done after 
coupling to insulin, as described by Knutson (1987}, 
undesireable iodination of the insulin may occur. 
Indiscriminate radioiodination of insulin has been 
demonstrated to result in considerable loss of biological 
activity (Fraenkel - Conrat & Fraenkel - Conrat, 1950} and 
diiodination of tyrosine is thought to deactivate insulin 
(Linde & Hansen, 1974). Also, iodination of the affinity 
labelled insulin by using chloramine - T may result in 
various monoiodinated species of insulin, which have been 
shown to have different affinities for the insulin receptor 
(Podlecki et al., 1983). Thus, as shown in figure 1.1.2 only 
the SASD was iodinated, and after separation from 
noniodinated SASD, coupled to insulin. 
The methodology to derivatise the ~ chain of insulin at its 
N - terminal was established previously in this laboratory 
by Grant and von Holt (1987} resulting in a biologically 
fully active derivative. Thus it was decided to couple 
carrier - free (125I)SASD to Bl only. The~e are potentially 
3 coupling sites for SASD: phe Bl; gly Al; and lys B29. To 
·ensure coupling to Bl only, the insulin was derivatised to 
(N-Boc-glyAl, N6-Boc-lysB29}insulin prior to coupling to the 
SASD reagent. 
7 
1.1.2 Results 
1.1.2.1 The synthesis of (N-Boc-GlyA1, N6-Boc-LysB29)Insulin 
The diboc insulin was synthesised essentially as described 
by Geiger et al. (1971) except that the bocing agent was 2-
tert-butoxy-carbonyloximino-2-phenylacetonitrile (BOPA). 
The resultant product was analysed by reverse phase HPLC 
(figure 1.1.3) and the various fractions collected, 
lyophilised, and subjected to acid - urea PAGE. It is 
apparent from figure 1.1.3 that the predominant product 
(peak 1) is diboc-insulin. 
Quantitation of the products revealed that the diboc-insulin 
constituted approximately 80% of the product, a figure very 
similar to that reported by Geiger et al. (1971). Of 
interest is the fact that the reaction ran to completion 
under these conditions, since no insulin remained (figure 
1.1.3). 
There are theoretically two forms of diboc-insulin, 
differing in the residues which are derivatised with BOPA. 
Irrespective of reaction conditions employed, the gly Al is 
always derivatised so the two possible diboc-insulins are 
{N-boc-glyAl, N6-boc-lysB29)insulin or (N-boc-glyAl, N-boc-
pheBl)insulin. It was thus essential to confirm that the 
former derivative is the major product as shown by Geiger et 
al. (1971). The diboc-insulin was thus subjected to the 
first two steps of Edman degradation (figure 1.1.4). The 
first cleavage step (4a) produced a predominance of 
phenylalanine (1) and trace amounts of glycine (2) 
indicating that only phe Bl is unboced. The second cleavage 
step (4b) produced glycine Al and valine B2 and some 
8 
A B 
N N 
3 
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A (arbirary units) 
2 
Elution volume (ml) Elution volume(ml) 
Fiaure 1.1.4 Edman Deqradation of Diboc-Insulin to Establish 
the Identity of Peak 1 as (N-Boc-GlyAl, N-Boc-
LysB29) Insulin. 
A quantity of the lyophilised peak 1 fraction was subjected 
to the first (A) and second (B) steps of Edman degradation 
to ascertain whether phe-Bl was boced. The peaks are 
phenylalanine (1), glycine (2), and valine (3). The internal 
standard (N) is norleucine. This analysis was kindly 
undertaken by Prof. Brandt and Dr. Rodrigues. 
9 
phenylalanine carry - over due to insufficient coupling in 
the first step. The glycine cleavage results from the 
debocing of this residue during the first cleavage step. The 
results in figure 1.1.4 conclusively show that the 
synthesised diboc-insulin is (N-boc-glyAl, N-boc-
lysB29} insulin. 
1.1.2.2 The Synthesis of carrier - Free [125I]SASD 
1.1.2.2.1 The Iodination of SASD 
The iodination of a cleavable, photoactivatable 
heterobifunctional reagent should be performed under 
conditions which do not alter the azido moiety, the 
disulphide bridge, or the hydroxysuccinimide ester moiety. 
The latter two functions are theoretically vulnerable to 
reducing agents such as mercaptoethanol, whereas the ester 
moiety may be susceptible to hydrolysis under aqueous 
conditions. 
Despite reports that SASD has been iodinated in the presence 
of reducing agents (Knutson, 1987) and an aqueous enviroment 
(Shephard et al., 1988} it was deemed prudent to undertake 
the iodination in anhydrous conditions in the total absence 
of reducing agents. Thus SASD was dissolved in DMSO (10 mg / 
ml) and iodinated using iodogen (1,3,4,6 - tetrachloro-3a,6a 
- diphenylglycouril} instead of the commonly used chloramine 
- T method which requires the addition of reducing agent to 
terminate the reaction. Iodogen was coated onto the walls of 
the reaction vessels by the addition of 1 ml of a 1 mg / 50 
ml chloroform solution to the vessels and the subsequent 
evaporation of the solvent. 
10 
Rf 1 2 3 4 
0.76 0 
8:~9 
Figure 1.1.s. TLC Analysis of Iodinated SASD. 
SASD (50 µg / 30 µl of DMSO) was iodinated with 5 µl of 125I 
(5 mci / 50 µl) for 1 minute in an iodogen tube as described 
in 6.2.5. After iodination a predetermined quantity was 
applied to a TLC plate and the remainder incubated with 
100µ1 of 0.2 M glycine, pH 10.0 tor 10 minutes. On 
·completion of incubation a predetermined amount was applied 
to the TLC plate and run in a solvent of 
benzene:chlorotorm:ethyl acetate:acetic acid (1:1:1:0.l). 
The developed plate was then autoradiographed (typically tor 
20 minutes) . 
Lane 1: 3 µg of unlabelled SASD 
Lane 2: iodinated SASD 
Lane 3: iodinated SASD incubated with 0.2 M glycine, pH 10.0 
for 10 minutes. 
Lane 4: unlabelled SASD incubated with 0.2 M glycine, pH 
10.0 tor 10 minutes. 
11 
Typically, 50 µg of SASD was iodinated in an iodogen tube 
with 3 µl of 1251 (5 mci / 50 µl, Amersh?m) for 1 minute. 
Analysis of the iodinated products by thin layer 
chromatography (figure 1.1.5) reve~led the presence of two 
iodinated products (lane 2) with Rf values of 
o.70 and 0.67. The unlabelled SASD also contains two 
products with Rf values of 0.76 and 0.66. These values 
differ quite markedly from those of Shephard et al. (1988) 
who reported Rf values of 0.48 and 0.36 for unlabelled SASD 
and 0.42 and 0.38 for iodinated SASD. This discrepancy may 
result from the fact that these authors did not use 
analytical grade solvents for the TLC solvent system. 
(personal communication). Different amounts of water and/ 
or acetic acid in the solvent system may affect the , 
mobilities of ·the SASD components. 
Typically, approximately 70% of input 1251 was incorporated 
into the SASD constituents and of this 60% was incorporated 
into the component with a Rf value of 0.70. 
To determine which of components is the intact ester and not 
the hydrolysed ester i.e. 2-(p-azidosalicylamido)-1,3-
dithiopropionate (Shephard et al., 1988), the iodinated SASD 
was reacted with 0.2 M glycine, pH 10.0. Any ester present 
would be subjected to nucleophilic attack by glycine at the 
hydroxysuccinimide ester. As indicated in figure 1.1.5 
(lanes 3 & 4) there is a decrease in the components with Rf 
values 0.76 and 0.70 (mainly in the former) and a 
concomitant increase in a product with a very low mobility -
this probably represents the glycine derivative. The 
radioactive component with Rf 0.67 also decreased but to a 
smaller, and variable extent (figure 1.1.6, lane 3). From 
this it was concluded that both iodinated components ar~ 
reactive, but that the more mobile derivative is the 
principal intact ester component of SASD, an observation 
previously made by Shephard et al. (1988). This 
12 
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Piqure 1.1.6. The Separation of [125I]SASD from Unlabelled 
SASD by Reverse Phase HPLC.' 
3 
SASD was iodinated and subjected to reverse phase HPLC on a 
ClB column (figure 1.1.6 A) as described in 6.2.5. 
The elution of radioactivity was monitored by means of a 
Geiger counter and collected as 1 ml fractions (dotted 
line). After lyophilisation the fractions were resolubilised 
in a minimum volume of DMSO and pooled with the other 
fractions of the same peak. The pooled peaks were then 
subjected to rotary evaporation to remove the DMSO and the 
dried peaks stored at -20°c until required. 
An aliquot of Peak 2 was subjected to TLC and . 
autoradiography as described in figure 1:1.s. Figure 1.1.6 B 
is a typical result although for any given column it was 
13 
0 
found that there was a gradual increase in origin - bound 
radioactivity throughout the entire elution range with 
sustained column use. This is most probably due to a gradual 
leaching of 125r that had bound to the column. 
Lane 1: unfractionated [125I]SASD 
Lane 2: peak 2 
Lane 3: peak 2 incubated with 0.2 M glycine, pH 10.0. 
14 
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experiment also provides evidence that the ester moiety 
survives the iodination procedure. It is apparent that the 
second component is a contaminant of commercially available 
SASD (figure 1.1.5, lane 1), possibly the free acid, and not 
a result of the iodination procedure. 
Besides this contaminant.there is evidence that the SASD 
consists of a mixture of differently charged species 
{section 1.1.2.4). 
1.1.2.2.2 Preparing Carrier - Free [125z]SASD 
The iodinated SASD preparation consists of a mixture of 
mainly 125r, [125r]SASD, and underivatised SASD. In order to 
synthesise a carrier - free insulin derivative it is thus 
necessary to purify the [125r)SASD. 
Initial attempts at separating out the [125I]SASD from the 
contaminants involved the use of LH20 column chromatography 
in absolute ethanol but this system proved not to have the 
required resolving power to separate 125r from [125r)SASD. 
Next, reverse - phase HPLC using a C18 column was attempted 
in order to separate out the unlabelled SASD from the 
[125I]SASD. Using the conditions described in figure 1.1.6 
it was possible to perform this separation. This procedure 
also removes any trace amounts of 125r which eluted in the 
flow - through. The radioactive fractions were pooled and 
subjected to thin layer chromatography to ascertain their 
identities {figure 1.1.6 h). The radioactive fraction which 
coelutes with the unlabelled SASD does not contain any 
labelled SASD and its identity is unknown. However, peak 2 
consists of [125IJSASD , confirming that the [125r]SASD is 
separable to a carrier - free state. 
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Figure 1.1.1. HPLC Analysis of Bovine Insulin Subjected To 
coupling conditions in order to Ascertain Possible Disulfide 
Bond Exchange. 
100 µg of bovine insulin was dissolved in 60 µl coupling 
medium (DMSO:TEA in a ratio of 300:0.16) and incubated for 
16 hours at 37 't. The sample was then subjected to HPLC 
analysis as described in 6.2.3. 
Shown on the same figure are native bovine insulin dissolved 
in DMSO and subjected to HPLC (solid line); bovine insulin 
subjected to the coupling conditions(dashed line); and 
bovine insulin dissolved in coupling medium containing 5 % 
B-mercaptoethanol and boiled for 10 minutes, followed by 
cooling in the presence of air (dotted line) . 
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To ascertain whether the ester moiety was intact after this 
purification procedure, an aliquot of peak 2 was reacted 
with 0.2 M glycine, pH 10.0 for 10 minutes. As is evident 
from figure 1.1.6 b, lane 3, the ester does react i.e. the 
ester is not destroyed in the separation process. 
The penalty for obtaining carrier - free [125I]SASD was the 
loss of approximately half of the (125I]SASD due to 
irreversible adsorption by the column. Attempts to diminish 
losses at this step proved unsuccessful. 
Routinely the relevant fractions were pooled, lyophilised, 
and stored at -20°c until required. 
1.1.2.3 The Couplinq of Carrier - Free [125I]SASD to Diboc-
Insulin 
In order to preserve the integrity of the SASD ester moiety 
it was decided to undertake the coupling in DMSO, thereby 
eliminating the risk of hydrolysis which an aqueous medium 
' 
would pose. The coupling was allowed to proceed overnight at 
37°C for convenience, despite initial evidence indicating 
that maximum coupling was achieved within 4 hours. 
Of importance in the DMSO coupling medium is the amount of 
base required to ensure that the amine on the insulin 
remains unprotonated for the reaction. At the same time the 
conditions should be such that disulphide bond exchange in 
the insulin molecule does not occur. To optimise the 
coupling yield, various ratios of DMSO to triethylamine 
. . . 
(TEA) were tested. For 100 µg diboc-insulin as tne TFA salt 
per 60 µl coupling medium, DMSO : TEA ratios of 300 : 0.10 
and 300 : 0.16 (v/v) were found to be optimal. 
Disulfide bond exchange within the diboc-insulin under these 
17 
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Figure 1.1.a. HPLC Analysis of couplinq Products. 
200 µg diboc-insulin was incubated with 40 µg unlabelled 
SASD as described in 6.2.3. Upon completion of 
coupling, the reaction medium was evaporated by rotary 
evaporation and so µl of anhydrous TFA added to facilitate 
debocing. After 3 minutes, the TFA was evaporated and the 
residue redissolved in 40 µl DMSO and subjected to HPLC 
separation (figure 1.1.8 A). 
1ml fractions of peak 2 were collected, lyophilised and 
identity confirmed by acid - urea PAGE (figure 1.1.8 BJ . 
. Lane l: diboc-insulin 
Lane 2: insulin 
Lane 3: peak 2 
Peak l is uncoupled insulin. 
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conditions was investigated by incubating diboc-insulin in 
these media for 16 hours at 37°C. Subsequent HPLC analysis 
revealed no change in retention time (figure 1.1.7). 
Intermolecular or intramolecular rearrangement would 
probably have resulted in the formation of heteropolymers 
with different elution profiles. It was thus concluded that 
the insulin molecules are not affected by exposure to these 
conditions. 
On completion of coupling, the reaction cocktail would 
consist of coupled [125I]ASD-diboc-insulin, (125I]SASD, and 
uncoupled diboc-insulin. It was decided to deboc the 
products prior to purification of the photoactivatable 
product ([125I]ASD-insulin) as this would minimise the 
number of manipulations. 
Initial experiments to define optimal conditions for the 
synthesis of SASD derivatised insulin in the DMSO / TEA 
buff er system and to test the separation of the reaction 
products were undertaken using unlabelled SASD as described 
in figure 1.1.8. The decrease in the amount of insulin (peak 
1) and concurrent appearance of peak 2 served to monitor the 
coupling yield. The presence of insulin (peak 1) and total 
absence of residual diboc-insulin indicates that the 3 
minute debocing procedure is sufficient. 
Confirmation that peak 2 is derivatised insulin was obtained 
by acid - urea PAGE (figure 1.1.a b), where the derivative 
having the same number of charged groups as diboc insulin 
exhibits a similar mobility. 
The determination of which DMSO TEA ratio to use (300 : 
0.10 or 300 : 0.16) was done by coupling carrier - free 
125I]SASD to diboc-insulin and determining the degree of 
incorporation by thin layer chromatography (figure 1.1.9). 
Derivatised insulin remains at the origin thus allowing 
direct determination by scraping and counting. This value 
was corrected to take into account the small amount of 
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protocol step % radioactivity 
incorporated 
% radioactivity 
recovered 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
SASD iodination(l) 
HPLc(2) 
Coupling(3) 
HPLc(4) 
70% 
I 
75% 
I 
I 
36% 
I 
40% 
Table 1.1.1. Summary of the Efficiency of Recovery of 
Radioactivity at Each Step in the Synthesis of carrier -
Free [125I]SASD - Derivatised Insulin. 
% incorporation refers to the percentage of input 125z 
incorporated into SASD(l) and the percentage of input 
carrier - free [125z]SASD coupled to insulin(3). 
% recovery refers to the percentage of input [125I]SASD 
recovered as carrier - free product after HPLC 
purification(2) and the percentage of input [125I}ASD-
insulin recovered as carrier - free product after HPLC 
purification(4). 
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radioactivity (presumably 125I) at the origin in lane 3. It 
was found that the coupling efficiency was 66% and 75% for 
the DMSO : TEA ratio of 300 : 0.10 and 300 : 0.16 
respectively. Thus subsequent coupling procedures were 
executed at the latter ratio. 
Using the optimised conditions and the finalised protocol 
illustrated in figure 1.1.2, carrier - free [125IJSASD was 
coupled to diboc-insulin and the deboced product purified by 
HPLC (figure 1.1.10 a). The identity of the radioactive peak 
as carrier - free [125IJASD•insulin was confirmed by acid -
urea PAGE (figure 1.1.10 b), the radioactive band (lane 4) 
having very similar mobility to that of unlabelled 
derivatised insulin (cf. figure 1.1.8 b). 
Table 1.1.1 summarises the efficiency of transfer of 125I 
along the synthetic pathway. The data indicate that 
approximately 8% of input 125I is recoverable as carrier -
free [125IJASD-insulin. 
The possibility that the SASD may couple to other amino acid 
residues such as histidine was investigated by incubating 
triboc-insulin with carrier - free (125I)SASD under the 
established coupling conditions. If coupling occurs only at 
the 3 residues (phe Bl; gly Al; and lys B29) then triboc-
insulin should not couple. Any observed coupling would 
indicate that other residues are reactive toward SASD. Any 
such spurious coupling may have serious implications in 
terms of the conformation of the derivatised insulin. 
The amount of coupling to triboc-insulin was found to be 
less than 4% (compared to 75% coupling to diboc insulin 
(table 1.1.1) and it is possible that this represents the 
coupling of SASD to trace amounts of contaminating diboc-
insulin, since the diboc- and triboc-insulins elute closely 
on HPLC (figure 1.1.3). It was thus concluded that the 
coupling of SASD occurs only at phe-Bl. 
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riqure 1.1.t. Deteraination of Optiaal couplinq conditions. 
Carrier - free [125z]SASD was reacted with diboc-insulin in 
coupling media of differing DHSO:TEA ratios: either 300 : 
0.10 or 300 : 0.16. Equal amounts of the coupled mixtures 
were then subjected to TLC and subsequent autoradiography. 
The relevant spots were scraped and counted to determine the 
degree of coupling. 
Lane 1: coupling products coupled in DHSO : TEA (300 : 
0 .10) • 
Lane 2: coupling products coupled in DHSO : TEA (300 : 
0.16). 
Lane 3: carrier - free [125z]SASD (post HPLC purification). 
Lane 4: unfractionated iodinated SASD. 
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Figure 1.1.10. HPLC Separation of [125I)SASD - Derivatised 
Insulin from Underivatised Insulin 
Diboc-insulin was reacted with carrier - free (125z}SASD, 
deboced, and subjected to HPLC. Figure 1.1.10 A represents a 
typical separation profile (the dotted trace representing 
the radioactive profile) and is consistent with that 
obtained for non - radioactive SASD - derivatised insulin 
(see figure 1.1.8.). The asterisks(*) indicates the 
position at which unlabelled SASD - derivatised insulin 
elutes. l ml fractions of the major radioactive peak (peak 
2) were collected, pooled 'and after lyophilisation, analysed 
by acid - urea PAGE (figure 1.1.10 B). 
Lane 1: iodinated triboc - insulin standard. 
Lane 2: iodinated diboc - insulin standard. 
Lane 3: iodinated mixture of insulin, mono -, di -, and tri 
- boc insulins. 
Lane 4: radioactive peak 2. 
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1.1.2.4 SASD Heterogeneity 
Occasional heterogeneity of the synthesised ASD-insulin was 
observed, a typical example of which is illustrated in 
figure 1.1.11. Analysis by acid - urea PAGE revealed that 
these fractions differ in charge (inset). This phenomenon 
does not appear to be a function of the coupling conditions 
since coupling undertaken at DMSO : TEA ratios of 300 : 0.10 
and 300 : 0.16 gave the same result. That this was not due 
to rearrangement of insulin under the coupling conditions is 
demonstrated in figure 1.1.7. Also discounted is the 
possible modification of insulin (eg deamination) during any 
one of the· subsequent synthesis steps. As can be seen in 
figure 1.1.12, the charge of the insulin molecule is 
unaffected by any reagent with which it comes into contact 
during the modification reactions. 
However, the use of a new C18 reverse phase column allowed 
the separation of SASD into various components (figure 
1.1.13 a). The ratio of 1: 2: 3 : 4 was found to be 1 
6.25 : 25 : 2.5 based on the absorbance at 260 nm. This 
heterogeneity was found to be identical for different 
batches purchased over a period of 24 months. Coupling of 
diboc-insulin with these separated components and subsequent 
acid - urea PAGE provided evidence that it is indeed the 
heterogeneity of the SASD which is responsible for the 
heterogeneity of the final insulin derivative (figure 1.1.13 
b). Of interest is the observation that peaks 1 and 3 
produce derivatives of the same charge. It is only peak 2 
which differs. The lower bands in lanes 1, 3, and 4 
represent uncoupled insulin which is still present owing to 
the fact that after coupl~ng, the products were not 
subjected to HPLC. The very low coupling yield of fraction 4 
may be the result of the comparatively small amount of ester 
input. 
Iodination of the various SASD components reveals that all 
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contain the desired ester in different amounts, although 
peak 2 contains two readily iodinatable species with Rf 
values between 0.43 and 0.48 (figure 1.1.13 c). This is of 
interest since it is the insulin derivatised with peak 2 
which differs in charge. Iodination of SASD "out of the 
bottle" also results in species with Rf values 0.40 - 0.50, 
indicating that this is a contaminant and does not result 
from any modification during use. The precise nature of 
these species is unknown and in the interest of minimising 
manipulations it was decided not to attempt to separate them 
out prior to derivatising insulin. This decision was based 
on TLC evidence that these species do not couple to diboc-
insulin since there is no decrease in the species after 
coupling (figure 1.1.9, lanes 1 & 2). The possibility that 
these species are generated from the ester during TLC is 
excluded, since there is no concomitant increase of these 
species with increase in the amount of ester (figure 1.1.9, 
lanes 3 & 4). Spectroscopic analysis of the fractionated 
peaks in figure i.1.13 a reveal that the various components 
of SASD have different absorption maxima (figure 1.1.14 a). 
However, exposure to ultraviolet light reduced the 
absorption of all fractions, indicating that all components 
are photoactivatable (figure 1.1.14 b - e). The absorption 
maxima and level of photoactivation are consistent with the 
findings of Wollenweber & Morrison (1985) for unfractionated 
SASD. 
In conclusion, charge heterogeneity of the SASD -
derivatised insulin is not a result of modifications during 
synthesis but is rather a reflection of the inherent 
heterogeneity of the SASD itself. Fractionation of the SASD 
prior to. coupling to insulin was deemed to be unnecessary 
since all the components can couple to insulin, are 
iodinatable, and are photoactivatable. 
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liqure 1,1,11, HPLC Demonstration of the Heterogeneity Of 
SASD - Derivatised Insulin. 
Unlabelled SASD - derivatised insulin was synthesised 
(6.2.3) and subjected to HPLC. l ml fractions of the product 
peak were collected and the fractions corresponding to the 
sections l, 2, and 3 of the peak pooled separately. 
After lyophilisation the pooled fractions were subjected to 
acid - urea PAGE (inset). 
The PAGE lane designations correspond to peak sections. 
standards were diboc-insulin (DJ and insulin (I). 
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Figure 1.1.12. Acid Urea PAGE of Bovine Insulin Exposed To 
all the Solvents Used in the synthesis of SASD - Derivatised 
Insulin. 
100 µg of bovine insulin was subjected to various solvents 
under the identical conditions that are encountered during 
the synthesis, and then subjected to acid - urea PAGE to 
determine whether any charge changes had occurred. 
Lane 1: insulin + DMSO · • 
Lane 2: insulin + DMSO : TEA (300 : 0.16) 
Lane 3: insulin + ether 
Lane 4: insulin + TFA 
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Figure 1,1,13, Separation of SASD Into its Various 
components and Their Subsequent couplinq to Diboc-Insulin. 
SASD was subjected to HPLC using a ClB column with larger 
plate number and a modified gradient profile (figure l.l.13 
A). The peaks were collected and pooled with corresponding 
peaks from successive runs and lyophilised. 
The various fractions were then used to derivatise diboc-
insulin in the usual manner. After debocing, the samples 
were subjected to acid - urea PAGE (figure l.l.13 B). The 
lane numberings correspond to peak designations in figure 
l.l.13 A. 
Lane 5: insulin standard. 
Lane 6: diboc - insulin standard. 
Prior to coupling an aliquot of each peak was iodinated and 
the products analysed by TLC (figure l.l.13 CJ. Lane 
designations are as in figure l.l.13 A. 
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Figure 1.1.14 The Photolability of the components of SASD. 
SASD was separated out into its various components as 
described for figure 1.1.13 A. The separated fractions were 
lyophilised and then solubilised in a minimum of DMSO and 
then made to 1 ml with phosphate buffered saline (PBS), pH 
7.4. The various peaks were scanned from 230 nm - 360 nm. 
The peaks were scanned before (-) and after (+) 
photoflashing. The results for peaks 1 - 4 (figure 1.1.13 A) 
are represented in A - D respectively. A direct comparison 
of the absorption spectra of the various components prior to 
photoflashing is shown in E. The peak designations 
correspond to the separated peaks in figure 1.1.13 A. 
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1.1.2.5 The Biological Activity ~f the Synthesised Carrier-
Free [125I]ASD-insulin 
Before using the synthesised insulin derivative to probe for 
intracellular insulin binding sites it was important to 
establish its biological activity with respect to native 
insulin. This was done by determining the derivative's 
ability to bind plasma membrane - bound receptor in vivo; to 
'induce known insulin target genes in situ; and to induce 
hypoglycaemia in mice (a reflection of the overall insulin 
effect). 
The autoradiogram in figure 1.1.15 is typical of the binding 
pattern of the plasma membrane fraction achieved when the 
derivatised insulin was incubated with hepatoma cells. The 
major labelled band (approximately 130 kD) corresponds to 
the insulin - binding a subunit of the insulin receptor. The 
labelling of this band is insulin - specific (figure 1.1.15, 
lane 2) indicating that the insulin derivative does indeed 
bind to the insulin receptor in a specific manner. There is 
some minor labelling of a band in the 95 kD range, possibly 
the B subunit of the insulin receptor (see 1.1.3). This may 
reflect some non - specific labelling of the subunit when 
the ASD-insulin is bound to the a subunit. 
The ability of the derivatised insulin to induce a response 
"in vivo" was ascertained by testing its ability to induce a 
hypoglycemic state in mice. The results summarised in figure 
1.1.16 demonstrate that the ASD - insulin readily induced a 
hypoglycemic· coma at a level comparable to that of native 
insulin. 
The mouse drop test represents a general in vivo response to 
insulin. It was therefore deemed desirable to investigate 
more specific effects i.e. at the level of the gene. A 
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Piqure 1.1.15 The In Situ Labellinq of the Hepatoma Plasma 
Membrane - Bound Insulin Receptor by carrier - Free 
[125I)ASD-Insulin. 
The labelling studies were performed as described in 6.3.4. 
Hepatoma cells were grown to confluency (3 x 107 cells / 
flask) and starved of serum overnight prior to the labelling 
studies. The medium was removed and 4ml of binding medium 
(HEM, 0.1% BSA, 20 mM HEPES, pH 7.4) added. [125z]ASD-
insulin (2 µCi) was added to each flask and the cells were 
incubated for 2 hours at 4 't to prevent receptor 
internalisation (lane 1). For competition studies 100 µM 
cold insulin was added to the medium (lane 2) 
Arter incubation, the medium was decanted and the cells were 
extensively washed and fresh medium added. The flasks were 
then subjected to ultraviolet radiation for 3 minutes and 
subsequently detached. The cells were homogenised in 0.32 M 
sucrose, TKM and subjected to a 10 minute spin at 800 g. The 
resultant supernatant was centrifuged at 38000 g for 30 
minutes and this plasma membrane fraction subjected to SDS 
PAGE. 
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Figure 1.1.16 In Vivo Response to ASD-Insulin: the Induction 
of Hypoglycemia in Balp c Mice. 
Groups of 2o mice each (average weight 30 g) were created by 
random selection and maintained in the same groupings for 
the duration of the experiments. These were designated 
insulin high, insulin low, ASD-insulin high, and ASD-insulin 
low. , 
The mice were starved for 6 hours and acclimatised at 37 ~ 
for 1 hour prior to the experiments. The mice were injected 
.intraperitoneally with either insulin (low dose 18 mu; high° 
dose 36 mU) or ASD-insulin (low dose 0.8 µg; high dose 1:.6 
µg) and placed on mesh racks inclined at 60 ': Hypoglycemia 
resulted in the mice slipping off the racks (early warning 
system) and convulsing. The mice were resuscitated with an 
intraperitoneal injection of 0.5 ml of 15 % glucose (zero 
mortality rate was experienced). These mice were· deemed to 
be hypoglycemic. The mice remaining on the racks after 1 
hour were counted. 
The experiment was repeated using different permutations of 
groups and dosages (see 6.3.7.). This figure represents an 
average value for the experiments. 
Experiments were also performed using intermediate dosages 
(insulin 29 mu; and ASD-insulin 1.2 µg). 
A, B, and C are high, intermediate, and low dosages 
respectively. 
1, 2, and 3 are placebo, insulin, and ASD-insulin 
respectively. 
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hepatoma cell line {H4IIE) was incubated with ASD-insulin 
and the induction of known insulin - responsive genes was 
ascertained by the use of appropriate mRNA probes {pyruvate 
kinase and tyrosine amino transferase) as described in 
section 6.3.6. ASD-insulin increased pyruvate kinase mRNA 
levels 1,93 - fold and TAT mRNA levels 1,42 - fold above 
that of the control {figure 1.1.17). These increases are 
similar to those for native insulin {2,4 - fold and 1,67 -
fold for pyruvate kinase and tyrosine amino transferase, 
respectively). I am indebted to Dr. Brenda Stickells, who 
optimised and carried out these gene - induction studies. 
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Figure 1.1.11. Determination of ASD-Insulin Stimulated Gene 
Induction in Hepatoma Cells 
Pyruvate kinase and tyrosine amino transf erase gene 
induction studies were undertaken as described in 6.3.6. 
Briefly, hepatoma H4IIE were incubated with either 10 mM 
ASD-insulin or natural insulin for 180 minutes and the total 
·RNA isolated using CsCl gradient fractionation. After 
crosslinking to Hybond N, the RNA was probed with pyruvate 
kinase and tyrosine amino transferase probes. The blots were 
then autoradiographed and the resultant autoradiograms 
subjected to densitometric scans in order to quantitate the 
levels of mRNA present. The average SEM for two separate 
experiments was 0.2. 
A: Pyruvate kinase gene induction. 
1) control; 2) natural insulin; 3) ASD - insulin. 
B: Tyrosine amino transferase gene induction. 
1) control; 2) natural insulin; 3) ASD - insulin. 
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1.1.3 Discussion 
This section details the synthesis and characterisation of 
carrier - free [125r]ASD-insulin. The [125r]ASD-insulin has 
been shown to be fully biologically active in that it 
specifically binds the plasma membrane insulin receptor 
(figure 1.1.15); it induces hypoglycemia in mice to a level 
comparable to native insulin (figure 1.1.16); and it induces 
the transcription of insulin - specific genes in hepatoma 
cells (figure 1.1.17). 
The labelling pattern for plasma membrane receptor (figure 
1.1.15) is similar to previous reports (Knutson, 1987; 
Hofmann et al., 1981; and Heidenreich et al., 1985) in that 
the major labelled protein is the 130 kD subunit. Knutson 
(1987) reports labelling of 130 kD exclusively, whereas the 
latter authors do show minor labelling of the 90 kD subunit. 
Podlecki et al. (1987) have also demonstrated the labelling 
of the 90 kD subunit. Of interest are the labelled high 
molecular weight bands (figure 1.1.15) which may represent 
unreduced receptor complex as demonstrated by Heidenreich et 
al. (1985). The labelling of the 130 kD subunit is in 
agreement with its role as the insulin binding subunit. 
There are numerous reports of ligands derivatised with 
iodinated photoaffinity reagents but most are either not 
carrier - free or are iodinated after derivatisation i.e. 
both ligand and photoaff inity reagent are labelled {Knutson, 
1987; Wollenweber & Morrison, 1985; Podlecki et al., 1987; 
Baenziger & Fiete, 1982; Heidenreich et al., 1985). However, 
a carrier - free cardiac glycoside photoaffinity derivative 
has been reported (Lowndes et al., 1988). 
The derivatisation of insulin with photoaffinity labels has 
been reported (Knutson, 1987; Heidenreich et al., 1985; Yip 
et al., 1980; Yip et al., 1978; Podlecki et al., 1987) even 
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using SASD (Knutson, 1987) but either the insulin was 
iodinated (Knutson, 1987; Heidenreich et al., 1985; Yip et 
al., 1980; Yip et al., 1978) or the final product was not 
carrier - free (Hofmann et al., 1981; Yip et al., 1978). 
To my knowledge this is the first report of a carrier - free 
photoactivatable insulin derivative that is not iodinated on 
the insulin molecule. 
The importance of a carrier - free insulin derivative is 
highlighted in the following consideration: 
Assuming 1 x 104 insulin receptors per cell, an in situ 
experiment involving 1 x 107 cells, exhibiting, say, 5% 
unoccupied receptors, would be expected to result in 5 x 109 
bound insulin molecules. Assuming that photoactivated cross 
- linking operates at approximately 2% efficiency, the final 
number of insulin molecules covalently cross - linked to 
their receptors is 1 x 108. As 1 Ci 125r corresponds to 2.74 
x 1017 atoms of iodine, the cross - linked insulin molecules 
correspond to 1 x 108 / 2.74 x 1017 = 3.65 x 10-10 Ci or 810 
d.p.m. on the plasma membrane. Thus the need for carrier -
free, photoactivatable insulin derivative as a probe for 
intracellular receptors, where the receptor concentration 
may be much lower than on the plasma membrane, is obvious. 
37 
1.2. The Use of Carrier - Free [125I]ASD-Insulin to Probe 
for Nuclear Envelope Insulin Docking Proteins 
1.2.1 Introduction 
In vitro studies using [125r]insulin have been interpreted 
to demonstrate insulin binding sites at the level of the 
nucleus (Horvat et al, 1973; Goidl, 1979; Vigneri et al., 
1978 a & b; Goldfine & Smith, 1976), the endoplasmic 
reticulum and the Golgi complex (Bergeron et al., 1973). 
current opinion is that the major nuclear - binding site is 
the nuclear envelope (Vigneri et al., 1978 a) although it 
has been reported that binding at the level of chromatin 
does exist (Smith & Jarrett, 1987). These authors 
demonstrated insulin binding at the periphery of condensed 
chromatin near the nuclear pore complex. The evidence for 
insulin intracellular binding sites has been comprehensively 
reviewed (Goldfine, 1987; Goldfine et al.~ 1985; Goldfine et 
al., 1982 a & b). 
Biochemical and immunological studies of the putative 
nuclear envelope - associated insulin receptor have shown it 
to be distinct from that of the plasma membrane receptor 
(Goldfine et al., 1977b; Vigneri et al., 1978 a) although a 
recent report (Wong et al., 1988) has shown the receptor 
isolated from nuclei to be virtually identical, by gel 
electrophoretic criteria, to that of the isolated plasma 
membrane receptor. These authors attribute thi~ discrepancy 
to the fact that all previous studies were done with 
membrane - bound receptor and that differences in the 
receptor properties may actually reflect differences in 
membrane enviroments. 
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This in vitro evidence is corrob9rated by in vivo studies, 
demonstrating the internalisation and subsequent binding of 
label from radioactive instilin to intracellular organelles. 
Using insulin labelled by either 125r, fluorescent dyes such 
as rhodamine, or electron dense moieties such as ferritin, 
the internalisation and eventual accumulation of label in 
the nucleus has been demonstrated in hepatocytes, rat 
diaphragm, lymphocytes, and adipocytes (for an extensive 
review.see Goldfine, 1981). Briefly, these studies involved 
the administration of labelled insulin in vivo or in vitro 
and subsequent subfractionation. Determination of label 
localisation was by autoradiography, electron microscopy, or 
light microscopy (Carpentier et al., 1978; Carpentier et 
al., 1979; Goldfine et al., 1977a & b; Goldfine, 1981; Smith 
& Jarrett, 1987; Schlesinger et al., 1978), depending on the 
derivatisation of the insulin molecule. Label binding has 
been demonstrated to occur within 15 - 30 minutes (Goldfine 
et al., 1977a; Smith and Jarrett, 1987). The latter authors 
found 3% of internalised insulin to be accumulated at the 
nucleus within 60 minutes. These findings appear to be 
significant because excess cold insulin almost completely 
inhibited the association of ferritin - insulin with nuclei 
(Smith & Jarett, 1987). 
The above findings strongly suggest that insulin interacts 
with the nuclear envelope and complement the findings that 
insulin directly influences nuclear envelope functioning 
(see 4.1). In an attempt to expand on the above evidence, 
the photoactivatable insulin derivative (synthesised as 
described in 1.1.2) was used to probe for putative 
intracellular insulin binding proteins. This section 
summarises the findings of this investigation. 
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ligurt 1,2,1 Probinq for Insulin - Bindinq Proteins in 
Isolated Rat Liver Nuclear Envelop••· 
2 
Rat liver nuclear envelopes (200 µg) isolated by the method 
oL Bornens and Courvalin, (1978) (Al & Bl) and Kaufmann et 
al. (1983) (A2 & B2) were incubated with carrier - free 
[12!z)ASD - insulin (6.3.5) and subjected to one dimensional 
SDS PAGE and autoradiography (6.4.7.3). 
A: incubation with [125z)ASD - insulin at 4°C 
B: incubation with [125z)ASD - insulin at 22°c. 
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1.2.2 Results 
The biological activity of the synthesised insulin analogue 
was investigated using intact hepatoma cells (figure 
1.1.15), since this system ensures an intact plasma 
membrane. However, rat liver was used to investigate the 
existence of intracellular insulin - docking polypeptides 
because the preparation of highly purified nuclei from rat 
liver homogenate is more convenient than it is from cultured 
hepatoma cells. 
Attempts to probe for specific insulin binding proteins in 
purified rat liver nuclear envelopes were unsuccessful (a 
typical result is demonstrated in figure 1.2.1). There was 
consistently a high background, especially at temperatures 
above 4°C (figure 1.2.1 B). This is possibly due to 
increased membrane fluidity, resulting in increased 
insertion of the hydrophobic SASD moiety into the lipid 
double layer. To circumvent this problem and to avoid 
possible alteration of the putative insulin receptors prior 
to the binding studies, whole nuclei were incubated with the 
derivatised insulin. Subsequently the nuclear envelopes were 
isolated after crosslinking with u.v. radiation. A typical 
insulin binding study with rat liver nuclei is shown in 
figure 1.2.2 A. A very faint band with a molecular weight of 
approximately 135 kD (figure 1.2.2 A, lane 1) is absent when 
excess cold insulin is added to the incubation mixture 
(figure 1.2.2 A, lane 2). Comparative scanning also 
indicated that only one fraction significantly decreased in 
labelling (average 30%) as the result of quenching with free 
insulin, confirming the visual observations (figure 1.2.2 
A) • 
In addition a further polypeptide of approximately 60 kD was 
specifically labelled (figure 1.2.3). This band is 
completely absent in control experiments, even when the 
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autoradiograms were overexposed (figure 1.2.3., inset). 
Attempts were made to emulate the results of Wong et al. 
(1988) by preparing wheat germ agglutinin extracts of 
isolated rat liver nuclei and then labelling these extracts 
with the derivatised insulin (figure 1.2.2 B). The resultant 
autoradiograms proved to be difficult to interpret because 
discrete bands were not obtained. Figure 1.2.2 B indicates a 
diffuse, labelled region in the 130 kD range. overexposure 
of autoradiographs from incubates with excess cold insulin 
did not reveal a similar region in the gel (figure 1.2.2 B, 
lane 2). The result indicates that there may be an 
enrichment of an insulin - binding protein wi th a molecular 
weight close to that of the plasma membrane insulin subunit, 
however a high non - specific binding and / or proteolytic 
degradation obscures the result and does not allow any real 
conclusion to be drawn. 
In Friend cell nuclei a region in the 130 kD range appears 
to become labelled by insulin (figure ·1.2.4). Friend cells 
have been reported by some authors to be responsive 
(Ginsberg et al., 1979; Ginsberg et al., 1981; Simon et al., 
1987). However, there was again heavy non - specific 
binding. 
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liqure 1,2,2 Probing for Insulin Binding Protein• in 
Isolated Rat Liver llUclei. 
Rat liver nuclei (A) isolated by the method of Blobel and 
Potter (1966) and wheat germ agglutinin extracts of nuclei 
(BJ prepared as described in (6.1.7) were incubated with 
carrier - ·free [125z)ASD-insulin, washed to remove unbound 
insulin and irradiated with u.v. radiation (6.3.5). 
The fractions were subjected to one dimensional SDS PAGE and 
autoradiography (6.4.7.3). 
A: rat liver nuclei incubated with carrier - free [125z)ASD 
-insulin in the absence (1) and presence (2) of 100 nH cold 
insulin. 
B: 1) wheat germ agglutinin extract of rat liver nuclei 
incubated with carrier - free {125z)ASD-insulin in the 
absence (1) and presence (2) of 100 nH cold insulin. 
C: densitometric scan of the autoradiogram in A. The symbols 
l & 2 and a - d correspond to those in A. The scans of the 
two lanes were standardised by an algorithm developed by Dr. 
Hugh Patterton, in order to correct for any variations in 
the amount of material loaded onto each lane. 
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1.2.3 Discussion 
The two major problems encountered in this study were the 
high background levels and the low intensity of the labelled 
polypeptides. This has made rigorous quantitation and 
interpretat1on very difficult. 
The high background effect was more acute when isolated 
nuclear envelopes were incubated with [125r]ASD-insulin, 
especially at higher temperatures (figure 1.2.2) ~ This may 
reflect a higher fluidity of the nuclear membrane at these 
temperatures which, in turn, may result in the non -
specific association of the SASD - derivatised insulin with 
the envelope' due to insertion of the hydrophobic SASD moiety 
into the fluid lipid layer. Subsequent washing may not 
remove the unbound insulin, and if in close proximity to 
other membrane proteins, may crosslink non - specifically 
when exposed to u.v. radiation. 
Furthermore, the low intensity of the labelled bands may be 
due to degradation or conformational changes of any putative 
insulin docking polypeptide as a result of the nuclear 
envelope isolation procedure. For example, it is recognised 
that nuclear envelopes isolated using heparin have a 
characteristic closed vesicular nature (Monneron et al., 
1972). Any putative insulin binding protein of the nuclear 
.envelope may thus be in an inverted conformation i.e. 
orientated toward the centre of such vesicles and thus be 
inaccessible to insulin. 
For all the above reasons the nuclear envelope fractions 
were isolated after incubation of the intact nuclei with 
insulin. In addition all procedures to isolate nuclei and 
nuclear envelopes were modified to eliminate reducing agents 
such as B - mercaptoethanol, thus ensuring that the insultn 
receptor (or receptor - like protein) was not reduced and 
possibly changing its solubility properties. 
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riqure 1.2.3 Demonstration of a Novel Insulin - Bin4inq 
Protein in the Nuclear Envelope of Rat Liver. 
Isolated nuclei (6.1.l) were incubated with carrier - free 
[125z)ASD-insulin in the presence (1) or absence (2) of 100 
nM cold insulin (6.3.5) and then subjected to one 
dimensional SDS PAGE and autoradiography (6.4.7.3). 
The inset shows an enlarged view of the indicated area. Lane 
l has been overexposed relative to lane 2 to demonstrate the 
lack of the 60kD protein in the presence of excess cold 
insulin 
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I have tried to use tissue with an increased number of free 
hypothetical intracellular insulin - binding sites, by using 
streptozotocin - induced diabetic rats. However, the livers 
from treated rats were invariably at an advanced state of 
degeneration even when removed from animals with moderate 
increases in blood glucose (see also section 4.3). 
No clear picture emerged from a wheat germ agglutinin -
binding fraction of rat liver nuclear envelopes (figure 
1.2.2 B), in that no discrete labelled bands were obtained. 
Only a diffuse labelled region in the 130 kD range is 
inhibited by excess cold insulin (figure 1.2.2 B, lane 2). 
The photoactivatable insulin analogue gave better results 
with Friend cell nuclei, pointing at the possible presence 
of a polypeptide in the 130 kD region, quenchable by excess 
cold insulin. 
Of interest is the insulin binding by an approximately 60 kD 
polypeptide (figure 1.2.3). Whether this constitutes a 
proteolytic fragment of the insulin receptor a subunit 
binding to insulin, remains to be seen. Increased 
susceptibility of the insulin receptor to tryptic cleavage 
after insulin binding and even a tryptic fragment with a 
molecular weight of 64 kD have been reported (Pilch and 
Czech, 1979; Donner and Yonkers, 1983). The possibility may 
also exist that this 60 kD polypeptide is not a degradation 
product and the 135 kD and 60 kD insulin binding proteins 
coexist and that, indeed, both are necessary for signal 
induction at the level of the nucleus (see chapter 5). 
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Piqure 1.2,4 Demonstration of a Nuclear Bnvelope Insulin 
Bindinq Protein in Prien4 Cella. 
Friend cell nuclei (6.1.5) were incubated with carrier -
free [125z]ASD-insulin in the presence (1) and absence (2) 
of 100 nM cold insulin (6.3.5) and subjected to one 
dimensional SDS PAGE and autoradiography (6.4.7.3). 
The Friend nuclei were shown by electron microscopy to be 
pure and intact. 
Overexposure of lane l (data not shown) failed to reveal any 
bands in the 45 - 205 kD molecular weight range. 
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Chapter 2 
The Enzymatic synthesis of carrier - Free 8-Azidoadenosine 
s·-c~32pl Triphosphate 
2.1. Introduction 
Azido photoaffinity analogues of nucleotide mono -, di -, 
and triphosphates are a powerful tool in the investigation 
of cellular regulatory processes. 
Azido-ATP (N3ATP) has been used in investigating the 
structure and mechanism of action of ATPases (Haley & 
Hoffman, 1974; Scheiner - Bobis & Schaner, 1985), the 
identification of membrane - bound ATPases and protein 
kinases (Roth & Cassel, 1983; Clawson et al., 1984; Coughlan 
& Hind, 1986), and in the investigation of receptor 
autokinases (Hapgood et al., 1986). N3ATP has also been 
employed in elucidating conformational changes in ATP -
binding enzymes (Reimann et al., 1988). 
Azido - derivatised guanine nucleotides, especially NJGTP, 
have been particularly powerful probes in the investigation 
of the mechanism of action of GTP - binding proteins (G 
proteins) in various systems (Peter et al., 1988; Schleicher 
et al., 1986; Droms et al., 1987). 
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Figure 2.1. The EnzYJ!latic synthesis of carrier - Free a-
Azidoadenosine S'-[~32p] Triphosphate. 
N3ATP: 8-azidoadenosine s'- triphosphate 
N3ADP: 8-azidoadenosine s'- diphosphate 
P* : phosphoryl residue 
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2.1.1 The synthesis of Azido-ATP 
2.1.1.1. Chemical synthesis 
A method for the chemical synthesis of azido analogues of 
adenine nucleotides is well documented (Czarnecki et al., 
1979) and is a modification of the method of Michelson 
(1964). This multi - step process entails the coupling of 
pyrophosphate to N3AMP which has been previously activated 
by incubation with diphenyl chlorophosphate. The N3ATP (30 -
50%) is separated from contaminating byproducts by DEAE -
cellulose chromatography. To synthesise [~32p]N3ATP, the 
pyrophosphate is spiked with 32ppi. The disadvantages of 
this methodology are the low specific activity of the 
product, the duration of the synthesis and the potential 
hazard of the chemicals used. 
2.1.1.2. Enzymatic synthesis 
Enzymatic methods have been reported (Glynn & Chappell, 
1964; Potter & Haley, 1983), but these are based either on 
exchange reactions between inorganic phosphate and the gamma 
phosphate of ATP (Glynn & Chappell, 1964) or require 
purification of the end product (Potter & Haley, 1983). This 
purification step of the final product to a carrier - free 
state is particularly important when investigating low 
abundance proteins, such as receptors. 
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Figure 2.2. TLC Characterisation of the Azido Product 
Synthesised in the Presence of 6 mM Dithiothreitol. 
The azido product was synthesised using the method of 
Johnson and Walseth (1979) for the synthesis of [~32P]ATP. 
This protocol is similar to that described in 6.2.1 with the 
major difference being the concentration of dithiothreitol 
(6 mM) • 
The reaction was monitored by a charcoal assay (6.4.11) and 
terminated by the addition of an equal volume of Tris -
saturated phenol. After extraction with chloroform an 
aliquot of the product was spotted onto a PEIE - cellulose 
TLC plate and run as described in 6.4.13. 
1) ADP; 2) N3ADP; 3) ATP; 4) N3ATP; 5) autoradiogram of the 
synthesis product. The non - radioactive standards (1 - 4) 
were visualised by fluorescence quenching under ultraviolet 
light. 
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This chapter describes the establishment of an enzymatic 
method for the synthesis' of carrier - free [732P]N3ATP by a 
single step process. The ~ethod is founded on the ability of 
N3ADP to act as a phosphoryl acceptor in the glycolytic 
pathway from 1,3,- diphosphoglyceric acid to 3 -
phosphoglycerate (figure 2.1). The product has been 
characterised and shown to meet all the criteria for a 
specific, photoreactive ATP analogue. 
2.2 Results 
2.2.1 synthesis 
The methodology employed is as described in (6.2.1}, except 
that the reagent mixture and the glycolytic enzyme mixture 
contained 15 mM and 5 mM dithiothreitol respectively. These 
are the amounts reported by Johnson and Walseth (1979} for 
the synthesis of radioactive adenine nucleotides. 
Initial syntheses yielded a main radioactive product with an 
Rf value different from N3ATP on TLC, (figure 2.2, lane 5). 
The azido product, without further purification, was used to 
photoaffinity label creatine kinase, known not to be an 
autokinase (thus excluding the complication of 
autophosphorylation}. Total incorporation was only 0.01%, 
which was far less than expected. This demonstrated that in 
all probability, the major product of the synthesis was not 
the expected azido compound and that there may.have been 
destruction or alteration. of the azido moeity during the 
synthesis. 
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Figure 2.3. TLC Analysis of the Products synthesised Using 
Different 6-Mercaptoethanol concentrations. 
The azido products were synthesised as described for figure 
2.2, except that dithiothreitol was substituted by B- · 
mercaptoethanol. 
Aliquots of the synthesised products were subjected to TLC 
as described in 6.4.13 and autoradiography (6.4.12). The 
standard non-radioactive ATP was visualised by means of 
fluorescence under ultraviolet light. 
1) ATP standard 
2) {-y32pjATP 
3) Product synthesised in the presence of 6 mM B -
mercaptoethanol. 
4) Product synthesised in the presence of 360 µM B -
mercaptoethanol. 
5) Product synthesised in the absence of B -mercaptoethanol. 
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The faint smudge above the main azido product (representing 
3% of the total radioactivity) was potentially interesting 
in that its Rf value was that of non - radioactive N3ATP. 
Thus, preparative TLCs were run and the corresponding area 
scraped (figure 2.2, lane 5). The radioactive product was 
eluted from the scrapings with 0.2 M ammonium bicarbonate 
and lyophilised. This product was found to photolabel 
creatine phosphokinase tenfold more effectively than the 
major synthesis product. 
The above results demonstrate that the major radioactive 
spot is not the desired product and that in fact it is the 
minor product (representing 3% of the total radioactivty) 
that constitutes (132PJN3ATP. 
The fact that the major product is not photoactivatable, 
focussed attention on the azido moeity which may undergo 
reduction to an amine derivative, rendering it inert, as a 
result of the presence of dithiothreitol (OTT) in the 
incubation mixture (used for the protection of the 
glycolytic enzymes). It was therefore decided to substitute 
the OTT with the milder reducing agent mercaptoethanol. 
Syntheses were performed with reagent mixtures containing no 
mercaptoethanol and glycolytic enzyme mixtures with varying 
amounts of the reducing agent. The products are dramatically 
different in that they consist either of 2 radioactive spots 
(figure 2.3, lane 3) or a single spot in the case of the 
product synthesised at a final mercaptoethanol concentration 
of 360 µM (figure 2.3, lane 4). In the total absence of 
mercaptoethanol (figure 2.3, lane 5) no defined product is 
synthesized. 
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Figure 2.4. The Effect of Increasing Protein Concentration 
on Specific (A) and Non - Specific (B,C) Labelling by 
[-y32p]N3ATP 
Various concentrations of the proteins were dissolved in 
incubation medium containing [~32PJN3ATP and after 2 minutes 
of preincubation exposed to eight 10 millisecond flashes 
from a ultraviolet flash system as described in 6.4.15. The 
proteins were then precipitated with trichloroacetic acid 
(10% final concentration) and subjected to SDS PAGE as 
described in 6.4.7.3. The bands were excised, placed in 10 
ml scintillation medium and counted. 
A) creatine kinase; B) bovine serum albumin; C) concanavalin 
A. 
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2.3. Characterisation of the ~ynthesised Azido Product 
2.3.1. TLC Mobility Studies 
Figure 2.3 summarises the TLC characterisation of the 
synthesised product. The product of synthesis 2 i.e. in the 
presence of 360 µM mercaptoethanol {lane 4) is virtually 
homogeneous and has a Rf value identical to that of ATP and 
N3ATP. The product of synthesis 1 i.e.in the presence of 6 
mM mercaptoethanol (lane 3) is a heterogeneous mixture as in 
figure 2.2, lane 5, indicating that the lower mobility 
fraction is dependent on a critical level of 
mercaptoethanol. The product at 360 ~M mercaptoethanol has 
the Rf of cold N3ATP. 
2.3.2 The Photoreactivity of the Products 
The products were incubated with creatine phosphokinase as 
described in section 6.3.1 and the incubation media exposed 
to ultraviolet radiation (section 6.4.15). After TCA 
precipitation and subsequent SDS PAGE, the extent of 
labelling of the enzyme was established (see legend of table 
2 .1) • 
The data (table 2.1) reveal that both products label 
creatine kinase and that this labelling for the· synthesis 2 
product is approximately twice that for the synthesis 1 
product. From this it can be concluded that the synthesis 2 
product constitutes the desired photoreactive azido 
compound in high yield. 
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Figure 2.s. The study of the Kinetics and Specificity of 
Hydrolysis of the Azido Product by Rabbit Skeletal 
[Ha+,K~]ATPase. 
[Na+,K+]ATPase (0.02 U / 250 µl) was incubated with varying 
amounts of the azido product and the degree of hydrolysis 
after 10 minutes determined by the charcoal assay (6.4.11). 
The rate of hydrolysis is represented as the number of moles 
of ATP hydrolysed / 0.02 U of enzyme / 10 minutes (6.4.4). 
Enzymatic reactions were executed in the absence (B) and 
presence (A) of cold ATP. 
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2.3.3 Labelling Specificity 
The specificity of labelling was ascertained by incubating 
the synthesis 2 azido product with various non - ATP -
binding proteins. The results in table 2.1 indicate that the 
azido product specifically labels only the kinase. 
Non - specific binding as a function of protein 
concentration was investigated and the results in figure 2.4 
clearly show that non - specific binding does not increase 
to any great extent with increasing concentration. 
2.3.4 Kinetic And Enzymatic studies 
The kinetic studies were undertaken using a [Na+, K+)ATPase 
as described in section 6.4.4. Various concentrations of the 
synthesised product were incubated with the ATPase and the 
rate of hydrolysis was determined by measuring the amount of 
liberated 32pi in an aliquot after 10 minutes. Lineweaver -
Burk analysis of the data (figure 2.5) reveals that the Km 
of hydrolysis is 10 µM and that competition with cold ATP is 
competitive (figure 2.5, B). 
2.4 Discussion 
An enzymatic protocol has been developed to synthesise 
carrier - free [132P)N3ATP in a single step, without the 
need for purification of the final product (Sabbatini & von 
Holt, 1987). 
This product has been shown to meet all the criteria for a 
specific, photoreactive ATP analogue. It has the same TLC 
mobility as ATP and nonradioactive N3ATP (figure 2.3); it is 
photoreactive (figures 2.4, table 2.1); it specifically 
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substrate u.v. Incorporation (c.p.m. > 
creatine kinase (1) + 3000 
200 
creatine kinase (2) + 6500 
260 
bovine serum albumin + 600 
310 
concanavalin A + 600 
280 
carbonic anhydrase + 450 
290 
soybean trypsin inhibitor + 650 
340 
alcohol dehydrogenase + 350 
280 
Table 2.1. Photoreactivity and Specificity of Labelling of 
the Synthesised Products. 
Labelling studies were undertaken as described in 6.3.1. 
1) synthesis 1 azido product 
Except for creatine kinase (1), all incubations were with 
the synthesis 2 azido product. 
The + and - in the u.v. column indicate the presence and 
absence of ultraviolet radiation. 
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labels a protein kinase (table 2.1); the Km of hydrolysis is 
very similar to that determined by Scheiner - Bobis & 
Schoner {1985) and the competitive inhibition by cold ATP 
indicates that the azido product is binding to a specific 
ATP - binding site. 
This synthesis protocol has distinct advantages over other 
methods. The chemical synthesis yields (30 - 50%) N3ATP 
which then has to be separated from contaminating N3AMP and 
an unidentified by - product (Czarnecki et al., 1979; 
Michelson, 1964). This method also employs potentially 
harmful reagents. The method of Potter and Haley {1983) 
results in a contaminating by - product, which could be the 
contaminant we encountered when relatively high quantities 
of mercaptoethanol or dithiothreitol are used. This problem 
is circumvented in our method by substituting 
mercaptoethanol for dithiothreitol and by decreasing the 
concentration of the reducing agent from 6 mM to 360 µM 
(final concentration). 
The carrier - free [132PJN3ATP has been used to probe for 
low quantity ATP - binding proteins in various cellular 
substructures (chapter 3) and to investigate direct effe?ts 
of insulin on these ATP - binding proteins (chapter 4). 
The importance of carrier - free (132PJN3ATP is illustrated 
by its use in investigating the putative protein kinase 
activity of the glucocorticoid hormone receptor complex 
(Appendix 1). These studies revealed the presence of a very 
low abundance protein kinase contaminant in the receptor 
preparation. The use of non - carrier - free [132PJN3ATP may 
not have provided such a definitive identification. 
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Chapter 3 
The Identification of Phosphoproteins and ATP - Binding 
Proteins in Intracellular Membranes 
3.1. Introduction 
There are indications in the literature and in the 
experiments presented of specific insulin binding by 
structures in the nucleus (see 2.2.1). Furthermore, insulin 
has been reported to directly modulate the phosphorylation 
state and activity of nuclear proteins (see 4.1). Thus, a 
study of the nuclear ATP - binding protein profile could 
make a contribution in the identification of kinases / 
NTPases that may be directly regulated by insulin. 
Protein Kinases 
Numerous nuclear envelope substrates for endogenous protein 
kinases have been identified (Lam & Kasper, 1979; Kletzien 
et al., 1981; Smith & Wells, 1983; Dessev et al., 1988; 
Rottman et al., 1987; Fisher, 1987; Gerace & Blobel, 1980; 
Ottaviano & Gerace, 1985; Fields et al., 1988; Hornbeck et 
al., 1988). A number of these phosphoproteins are associated 
with the nuclear pore complex (Lam & Kasper, 1979; steer et 
al., 1980; smith & Wells, '1983; Ahmed & steer, 1982; ~ottman 
et al., 1987) or the nuclear lamina (Dessev et al., 1988; 
Fisher, 1987; Gerace & Blobel, 1980; Ottaviano & Gerace, 
1985; Newport & Spann, 1987; Fields et al., 1988; Hornbeck 
et al., 1988). Smith and Wells (1983) have made a systematic 
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study of rat liver nuclear envelope phosphoproteins and have 
identified at least 12 such modified polypeptides, the most 
prominent (7, 20, 51, 59,and 70 kDa) being associated with 
the nuclear pore complex. 
The role of phosphorylation / dephosphorylation of the 
nuclear lamins in nuclear breakdown and reassembly is 
extensively documented. In mitosis, hyperphosphorylation of 
the lamins precedes nuclear envelope breakdown (Fisher, 
1987; Gerace & Blobel, 1980; Ottaviano & Gerace, 1985). This 
high degree of phosphorylation is thought to result in the 
depolymerisation of the lamina network as evidenced by the 
fact that lamins A and C are solubilized (Gerace & Blobel, 
1980; Ottaviano & Gerace, 1985; Miake - Lye & Kirschner, 
1985). Conversely, dephosphorylation of the solubilized 
lamins precedes polymerisation and marks the onset of 
nuclear reassembly (Burke & Gerace, 1986; Fisher, 1987; 
Peter et al, 1990). 
Ottaviano and Gerace (1985) have demonstrated that 
phosphorylation occurs only on assembled lamins indicating 
that an endogenous membrane - bound kinase is probably 
responsible. This finding is substantiated by the fact that 
the nuclear lamina contains a very tightly bound protein 
' kinase activity responsible for phosphorylating the lamins 
as well as several other polypeptides (Dessev et al., 1988). 
This kinase activity is ca2+ and cAMP independent. Lamin 
phosphorylation has been shown to be enhanced by the 
maturation promoting factor (MPF) from Xenopus oocytes and 
the possibility exists that this factor is a protein kinase 
which induces mitotic nuclear breakdown by phosphorylating 
the lamina, resulting in its depolymerization (Fisher, 1987; 
Miake-Lye & Kirschner, 1985). 
Recent results indicate induction of lamin phosp~orylation 
by ligands that activate protein kinase C (Fields et al., 
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riqurt 3.1. Th• Phosphorylation, H3ATP - Bindinq and 
concanavalin A - Binding Profile of Rat Liver Nuclear 
Envelop•• xsolated by Different Methods. 
Rat liver nuclear envelopes were isolated by various methods 
as described in 6.1.2. 
A: Coomassie pattern o~ nuclear envelope isolated by the 
methods of 1) Bornen• and Courvalin (1978) 2) Kaufmann et 
al. (1983) 3) Kay et al. (1972) 4) Kay et al. (1972) 5) 
Monneron et al. (1972). The nuclear envelopes in 3) are as 
for those in 4) except that they have undergone additional 
DNase 1 digestion. Thi• not only removed additional DNA but 
also the histones bound to the latter i.e. the two prominent 
low mobility bands. ~h• nuclear envelopes in lanes 6 - 10 
correspond to those in lanes 1 - 5. 
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B: N3ATP binding and phosphorylation pattern of the nuclear 
envelopes in A. The lane designations are as in A. 
Approximately 100 µg of nuclear envelope fraction was 
resuspended in 250 µl of incubation medium and incubated 
with either [~32P]N3ATP (lanes 1 - 5) or [~32P)ATP (lanes 6 
- 10) as described in 6.3.2 & 6.3.3, respectively. After 
incubation with [~32P]N3ATP, the envelopes were either 
solubilised immediately without exposure to u.v. radiation 
(-) or were irradiated (+) prior to solubilisation in sample 
application buffer. 
SDS PAGE and autoradiography were undertaken as described in 
6.4.7. 
' 
c: Concanavalin A binding pattern of rat liver nuclear 
envelopes isolated by the methods of 1) Bornens and 
Courvalin (1978) 2) Kaufmann et al. (1983) 3) Kay et al. 
(1972) and 4) Monneron et al. (1972). 
Concanavalin A studies were undertaken as described in 
6.4.5. 
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1988; Hornbeck et al., 1988). 'The implication here is that 
the lamin kinase{s) is / are not lamina associated. There 
are a number of possible mechanisms of protein kinase -
mediated phosphorylation of the lamins: ligands may 
translocate to the nucleus bound to specific complexes which 
then bind and activate protein kinase C {Hornbeck et al., 
1988); protein kinase C is activated, resulting in a 
phosphorylation cascade, finally activating a membrane -
bound lamin kinase with similar properties to protein kinase 
c; or protein kinase c may be cleaved to form a low 
molecular weight kinase {protein kinase M) which 
translocates to the nucleus. There is evidence for the 
latter model {Tapley. & Murray, 1985). These authors have 
demonstrated protein kinase M - induced phosphorylation of 
purified lamin B. 
Rottman et al. (1987) also provide evidence that the protein 
kinase responsible for the phosphorylation of certain 
nuclear pore complex lamina proteins (115, 90, 72 kDa) as 
well as topoisomerase 11 in the sponge Goedia cydonium is 
not a membrane - associated kinase but is instead protein 
kinase C which binds to the nuclear envelope upon activation 
by diacylglycerol. 
Conversely, many nuclear envelope proteins {Lam & Kasper, 
1979; Kletzien, 1981; Smith & Wells, 1983) are 
phosphorylated by cAMP - independent, Mg2+ - dependent 
kinases which appear to be endogenous to the nuclear 
envelope. Smith and Wells (1983) provide convincing evidence 
that this activity is confined to the nuclear pore complex. 
The stimulation of these kinases is independent of cyclic 
mono -nucleotides, calc~um, and calmodulin (Lam & Kasper, 
1979; Steer et al., 1980; Smith & Wells, 1983) although 
Steer and coworkers show a marked stimulation of kinase 
activity by cobalt. 
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Figure 3.2 coapariaon of th• B3ATP - Binding Profile of Cellular Substructure• Isolated from Various Tissues. 
1 
Approximately 100 µg oL each Lraction was resuspended in 250 
µl oL incubation medium and incubated with ( 1 2p}N3ATP 
(6.3.2.) and subjected to one dimensional SDS PAGE and 
autoradiography (6.4.7). 
The isolation procedures Lor plasma membrane, nuclear 
envelope, mitochondria, and Jltetaphase chromosomes are 
detailed in sections 6.1.3., 6.1.2., 6.1.4., and 6.1.6. 
respectively. 
A: 1) Rat liver plasma membrane 2) rat liver nuclear 
envelope isolated by the method oL Bornens and Courvalin 
(1978) 3) rat liver mitochondria. 
B: 1) Friend nuclear envelope isolated by the method of 
Bornens and Courvalin (1978) 2) Friend plasma membrane 3) 
Friend metaphase chromosomes. 
C: 1) Hepatoma HIIE nuclear envelope isolated by the method 
of Bornens and Courvalin (1978) 2) hepatoma HIIE plasma 
membrane. 
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2 
Nuclear envelope protein phos~ha~ase activity h~s been 
reported to be Mg2+-dependent and independent of cyclic 
mononucleotides (Steer et al., 1979 a & b). This activity is 
, 
firmly associated with the nuclear envelope as witnessed by 
the fact that even 1.4 M sodium chloride does not reduce the 
envelope phosphatase activity (Steer et al., 1979 b). These 
authors describe the presence of multiple types of 
phosphatases. 
Nucleoside Triphosphatases 
Th~ interpretation of experiments attempting to identify or 
characterize envelope proteins is difficult or often 
impossible because many of the published experimental, 
details do not unequivocally exclude possible contamination 
with other subcellular fractions. There has recently been 
" considerable progress toward the characterisation of the 
major rat liver nuclear envelope NTPase (46 kDa) which is 
postulated to be pivotal in insulin - stimulated mRNA efflux 
from the nucleus (see 4.1). 
Photoaffinity p~obing of nuclear envelope with azido 
analogues of ATP has identified a 46 kDa protein thought to 
be a major nuclear NTPase (Clawson et al., 1984). Schroder 
et al. (1986) designate to the purified enzyme a molecular 
weight of 40 kDa and Konder - Koch et al. (1982) a molecular 
weight of 47 kDa .. 
There is conflicting evidence concerning the detergent 
solubility of this enzyme. Clawson et al. (1985) have shown 
it to be insoluble and have assigned it to the nuclear 
matrix. Opposing evidence does exist (Schroder.~t al., 
~ 
1986). Ther~ is evidence however, that the enzyme is located 
at the nuclear pore complex (Agutter et al., 1979b), 
although this is not ·undisputed (Clawson et al., 1980a). 
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Figure 3.3 coaparison of th• Bl1ctropbor1tic Pattern of 
Polyp1pti41• fro• Cellular Substructures Isolated from 
variou• Ti••ues. 
1 
Approximately 100 µg of each fraction was solubilised in 60 
µl of sample application buffer· and subjected to one 
dimensional SDS PAGE (6.4.7). 
A: Coomassie pattern of 1) rat liver nuclear envelope 
isolated by the method of Bornens and Courvalin (1978) 2) 
rat liver nuclei 3) rat liver plasma membrane 4) Friend 
nuclear envelope isolated by the method of Bornens and 
Courvalin (1978) 5) Friend metaphase chromosomes. 
B: Coomassie pattern of 1) hepatoma HIIE plasma membranes 
and 2) hepatoma HIIE nuclear envelopes isolated by the 
method of Bornens and Courvalin (1978). 
C: Coomassie pattern of 1) rat liver mitochondria and 2) rat 
liver endoplasmic reticulum. 
The isolation of nuclei, nuclear envelopes, plasma membrane, 
mitochondria, and metaphase chromosomes is described in 
sections 6.1.1, 6.1.2, 6.1.3, 6.1.4, and 6.1.6 respectively. 
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2 
Unlike other NTPases this enzyme has been reported to have a 
broad specificity, hydrolyzing ATP, GTP, UTP and even CTP 
(Purrello et al., 1982; Schroder et al., 1986}. It has also 
been suggested that ADP may be utilized (Clawson et 
al.,1980b}. 
The stimulation of this ATPase by cAMP (Purrello et al., 
1982} and the polyA tail of mRNA (Bernd et al., 1982; 
Clawson et al., 1984} has led to the conclusion that these 
NTPases may play a role as the energy - generator necessary 
for nucleo - cytoplasmic translocation of mRNA (see 4.1). 
In previous investigations by other authors, the effects of 
insulin on the nuclear envelope protein phosphorylation 
state and NTPase activity has been expressed in terms of 
changes to the overall phosphorylation profile (Purrello et 
al., 1983} and to changes of the rate of ATP hydrolysis 
' (Purrello et al., 1982), respectively. However, no 
individual proteins involved in the change of 
phosphorylation state of the nucleus has been identified. 
To assess the validity of the involvement of the state of 
phosphorylation of nuclear envelope proteins it would be 
important to demonstrate the effects (if any) of insulin on 
' 
specjfic ATP - binding proteins (i.e. either protein 
kinases or ATPases). Any change in N3ATP binding of these 
proteins in the presence of insulin would represent evidence 
for the direct modulation of these nuclear enzymes by 
insulin. 
This chapter reports the results of the investigation of the 
N3ATP - binding proteins of the rat liver nuclear envelope 
and the comparison of the identified ATPases / kinases with 
those of other cellular structures from rat liver and 
various c~ll lines. This 'is an important first step in the 
identification of nuclear envelope protein kinases / ATPases 
that may be directly modulated by insulin (see chapter 4). 
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3.2. Results 
Prior to any studies on the effect of insulin on the rat 
liver nuclear envelope, it was important to determine 
whether the enzymatic profile of the isolated envelopes is 
dependent on the isolation methodology. Thus, rat liver 
nuclear envelopes were isolated by several different 
published methods and the ATP - binding and phosphorylation 
profiles compared (figure 3.1 A & B). Both the ATP - binding 
and phosphorylation pattern were found to be essentially 
independent of the isolation method employed. Consistently 
present in ATP - binding studies is a doublet at 
approximately 55 kD and a 46 kD species. Membranes isolated 
by the method of Monneron et al. (1972) (see 6.1.2.3) 
consistently had lower ATP - binding activity in the 55 kD 
range (figure 3.1 B, lane 5). The additional bands (figure 
3.1 B, lane 4) present in nuclear envelopes isolated by the 
method of Kay et al. (1972) (6.1.2.4) represent nuclear 
contaminants (figure 3.1 A, lane 4) because further DNase 1 
digestion eliminated these fractions (figure 3.1 A, lane 3). 
~t is obvious from the phosphorylation pattern (figure 3.1 
B, lanes 6 - 10) that the ATP - binding proteins in the 46 -
55 kD range are not autokinases. The heavy phosphorylation 
pattern (figure 3.1 B, lane 9) is due to nuclear 
contamination, as described above. 
The Coomassie - staining pattern is also essentially 
independent of the isolation procedure (figure 3.1 A) and 
this is corroborated by the Concanavalin A - binding pattern 
(figure 3.1 C), reflecting similar qualitative glycoprotein 
enrichment in the nuclear envelope fractions. Ohe 
significant difference is' the relatively low abundance of 
protein with the mobility of the lamin proteins (60 - 70 kD) 
in envelopes isolated by the method of Bornens and Courvalin 
(1978) (see 6.1.2.1). This is in agreement with published 
observations which indicate the solubilisation of 
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Figure 3.4 Two Dimensional PAGE of N3ATP - Labelled Rat 
Liver and Friend Fractions. 
A: Autoradiographs (12 hour exposure) of [132pJN3ATP 
labelled fractions. Approximately 250 µg of each fraction 
was labelled (6.3.2) and subjected to two dimensional PAGE 
(6.4.7). 
1) Rat liver nuclear envelope 2) rat liver plasma membrane 
3) rat liver mitochondria 4) Friend metaphase chromosomes. 
The crosses {X) indicate the positions of three marker 
proteins - from top to bottom: bovine serum albumin (M.W. 
68kD), ovalbumin (M.W. 45kD; pI 4.8), and carbonic anhydrase 
(M.W. 29kD; pI 6.1). 
B: Coomassie pattern. 1 - 4 correspond to 1. - 4 in A. The 
arrows indicate the positions of the azido ATP labelled 
proteins in A. The arrow indicated by the asterics (*) 
indicates the position of the 46 kD, azido labelled protein. 
For both A and B, the migration in the first dimension 
electrophoresis (IEF) is from right to left. Migration in 
the second direction electrophoresis (SDS) is from top to 
bottom. 
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the lamins by heparin. 
In order to establish whether the ATP - binding pattern 
found in rat liver nuclear envelopes is nuclear specific, a 
comparative study was undertaken. The ATP - binding pattern 
of rat liver mitochondria and plasma membrane was found to 
be essentially as that for nuclear envelope (figure 3.2 A), 
except for the presence of additional ATP - binding proteins 
in plasma membranes. The similarity in ATP - binding pattern 
of the various membrane preparations, including the extra -
nuclear ones, is all the more striking in the light of the 
differences in Coomassie profile of the various fractions 
(figure 3.3). 
To ensure that these results are not due to a coincidental 
similarity in electrophoretic mobility (i.e. similar 
molecular weight), certain of the fractions were analysed by 
two dimensional PAGE (figure 3.4). The ATP - binding pattern 
for rat liver nuclear envelope, plasma membrane, and 
mitochondria (figure 3.4 A; 1, 2, & 3 respectively) are 
almost identical, indicating that these structures possess a 
set of ATP - binding proteins of the same molecular weight 
and isoelectric point. It is evident from figure 3.4 B that 
the N3ATP - labelled proteins are closely related to 
Coomassie stained proteins. That the autoradiographic spots 
do not coincide precisely with a major Coomassie spot 
(figure 3 B) indicates that only a fraction of the protein 
is phosphorylated. This small phosphorylated component, 
being more acidic, migrates further in the first dimension 
isoelectric focussing gel. It was thus concluded that these 
subcellular fractions from various sources share a common 
set of ATP - binding proteins. 
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Piqur• 3.5 Determination of the GTP Binding Characteristics 
of the Rat Liver Plasma Membrane and Nuclear Envelope Azido 
Binding Proteins. 
A: Approximately 150 µg of plasma membrane (6.1.4) was 
resuspended in 250 µl of incubation medium and incubated 
with {l32p]N3ATP (6.3.2) in the presence of various 
concentrations of GTP and ATP. 
1) 10 µH ATP, 2) 500 nM ATP 3) 10 µM GTP 4) 500 nM GTP 5) no 
GTP. 
B: Approximately 150 µg of nuclear envelope isolated by the 
method of Kaufmann et al. (1983) was resuspended in 250 µl 
of incubation medium and GTP and ATP binding characteristics 
determined as for plasma membrane. 
1) 10 µM ATP 2) 500 nM ATP 3) 10 µM GTP 4) 500 nM GTP 5) no 
GTP. 
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The GTP - binding characteristics were also investigated. 
This was undertaken as a first step in the possible 
identification of nuclear envelope G proteins. Having 
concluded that the 55 kD doublet and the 46 kD protein are 
present in all the fractions investigated, GTP - binding 
studies were undertaken only on rat liver nuclear envelope 
and plasma membranes. The results (figure 3.5 A & B) 
indicate that GTP is not a substrate for either the plasma 
membrane or nuclear envelope 46 kD protein. In contrast, at 
500 nM ATP, there is a marked decrease in N3ATP - binding 
(figure 3.5 A & B, lanes 2). 
To further investigate the identity of the 46 kD, various 
membrane fractions were preincubated with quercetin, 
ouabain, and colchicine, and the inhibition characteristics 
compared. As evidenced in figure 3.6 A - c, the 
characteristics, namely prominent inhibition of ATP binding 
by quercetin, are identical, irrespective of the membrane 
investigated. 
The possibility that the presence of this seemingly 
ubiquitous 46 kD protein (as well as the 55 kD doublet) in 
nuclear envelope and also in chromosome preparations may be 
a result of cross - contamination during the isolation 
procedure was investigated. To this end N3ATP - labelled rat 
liver mitochondria, plasma membrane, and endoplasmic 
reticulum were added to separate non - radioactive rat liver 
homogenates prior to the first centrifugation and nuclei and 
nuclear envelopes were then isolated by established.methods. 
The autoradiographs after comparable exposure time (3 days) 
of the subsequent sos PAGE gels revealed no evidence of a 
radioactive 46 kD species in the nuclear envelqpe lanes 
(figure 3.7, 4 - 6). The autoradiographs were exposed for an 
additional 2 weeks, without any appearance of a 46 kD band. 
Thus cross - contamination during the isolation procedure as 
a cause for the ubiquitous presence of the 46 kD protein can 
be excluded. 
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Rat liver cells were the principal substrate for this 
investigation. However, for comparative purposes, other 
cells were investigated. Figure 3.2 C demonstrates the 
presence of the 46 kD N3ATP - binding polypeptide in 
hepatoma cells. The ATP - binding profile of Friend cell 
nuclear envelope (figure 3.2 B) is identical to that of the 
rat liver. The doublet at approximately 55 kD is absent in 
the metaphase chromosome fraction derived from these cells 
(figure 3.2 B, lane 3). The presence of the 46 kD N3ATP -
binding polypeptide was confirmed by the 20 PAGE analysis 
(figure 3.4 A, autoradiogram 4). 
3.3. Discussion 
The results presented in this chapter demonstrate that there 
is present in all rat liver subfractions investigated, a 
ubiquitous, ATP - binding 46 kD polypeptide chain. All these 
fractions also share two polypeptides in the range 53 - 58 
kD, which bind ATP. 
The N3ATP - binding 55 kD doublet present in all membrane 
fractions in all likelihood represents the same polypeptide 
because of identical molecular weight (figure 3.2 A, B, & 
C}, isoelectric point (figure 3.4 A}, and response to 
inhibitors (fig 3.6). 
The ubiquitous 46 kD N3ATP - binding protein exhibits 
identical properties in terms of molecular weight (figure 
4.2), isoelectric point (figure 3~4 A) and inhibition 
characteristics (figure 3.6). The widespread distribution 
has been demonstrated not to be an artefact of the isolation 
procedures (figure 3.7, lanes 4 - 6), and is in accordance 
with the findings of Rubins et al. (1990), who have 
demonstrated the existence of a 47 kD polypeptide in the 
nuclear envelope and rough endoplasmic reticulum. 
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Figure 3,§ Sensitivity of the 46kD Protein from Various 
Sul:>cellular rractiona to th• Inhibitors guercetin, Oul:>ain, 
and Colchicine. 
150 µg or each fraction was resuspended in 300 µl or 
incubation medium and preincubated with inhibitor for 5 
minutes at 22°c. Each fraction was then labelled with 
[-y32pj N3ATP (6.3.2). Arter irradiation, the fractions were 
pelleted, solubilised in 70 µl or sample application burrer 
and subjected to one dimensional SDS PAGE and subsequent 
autoradiography (6.4.7). 
A) Rat liver nuclear envelope B) rat liver plasma membrane 
C) rat liver endoplasmic reticulum 
For A - c: 1) no preincubation with inhibitor 2) 
preincubation with quercetin (10 µg / ml) 3) preincubation 
with oubain (1 mM) 4) preincubation with colchicine (1 mM). 
80 
This 46 kD protein shares many of the characteristics of the 
NTPase reported to be involved in nucleocytoplasmic 
translocation of mRNA. It binds N3ATP in ,a specific manner 
(figure 3.1 B, lanes 1 - 5}; it has a molecular weight 
similar to that reported by Clawson et al. (1984}; in 
agreement with the findings of the above authors, it is not 
phosphorylated nor solublized (Agutter et al., 1979a}; and 
the inhibition characteristics are similar to those reported 
for nuclear envelope ATPases (Agutter et al., 1979b}. 
The 46 kD protein, despite being a minor envelope component, 
is highly labelled by N3ATP (figure 3.1 A & B, lanes 1 - 5). 
This high affinity is in accordance with the results of 
Clawson et al. (1984), who reported the specific activity of 
this band to be up to 20 times greater than that of the more 
abundant 58 kD band. 
The isolation procedures for nuclear envelopes, in general, 
do not affect the yield of ATP - binding proteins (figure 
3.1 B, lanes 1 - 5). However, the phosphorylation pattern is 
more sensitive to the isolation parameters (figure 3.1, 
lanes 6 - 10} reflecting slight variations in protein kinase 
and / or substrate content. 
The inhibition characteristics are similar to those reported 
for both the nuclear envelope - bound and purified NTPase 
(Agutter et al., 1979b; Schroder et al., 1986). As figure 
3.6 illustrates, quercetin (10 µg / ml} significantly 
reduces labelling of the 46 kD protein. At this 
concentration, labelling was reduced by 80%. This inhibitory 
effect by quercetin is much more pronounced than that 
reported for the isolated NTPase (Schroder et el., 1986} and 
is in keeping with the observations of Agutter et al., 
(1979a & b} for the general nuclear envelope NTPase. The 
inhibition by quercetin is at odds with the report by 
Clawson et al. (1984}, stating no inhibition of 
photolabelling of the 46 kD protein to occur by this 
inhibitor in the presence of 5 mM Mgcl2 . 
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Piqur• 3.7 Absence of cross - Contamination of the 
Subcellular Fractions Investiqated. 
[-y32PJN3ATP labelled mitochondria (approximately 2 x 107dpm, plasma membrane (approximately 4 x 10~ dpm), and endoplasmic 
reticulum (approximately 3 x 106 dpm), was washed 
extensively to remove all excess label and pelleted. 
A rat liver homogenate (30 g liver) was divided in three 
prior to the tirst lOOOg centrifugation (6.1.1) and to each 
ot these tractions was added one ot the N3ATP labelled 
subcellular tractions. Nuclei were then isolated as 
described in 6.1.1 and subsequently nuclear envelopes were 
isolated by the method ot Bornens and Courvalin (1978). 
These envelope tractions were then subjected to one 
dimensional SDS PAGE and .extensive autoradiography (6.4.7). 
1) N3ATP - labelled mitochondria 2) N3ATP - labelled plasma 
membrane 3) N3ATP labelled endoplasmic reticulum 4) nuclear 
envelope isolated in the presence ot labelled mitochondria 
5) nuclear envelope isolated in the presence ot labelled 
plasma membrane 6) nuclear envelope isolated in the presence 
ot labelled endoplasmic reticulum. 
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This discrepancy may reflect a difference in methodology for 
the inhibition studies, the details of which have not been 
reported by Clawson et al. (1984). The use of quercetin for 
the identification of protein kinases (Clawson et al., 1984) 
is of doubtful value in the light of reports by Cantley and 
Hammes (1976) and Lang and Racker (1974). The investigations 
by these authors suggest that quercetin binds to ATP -
binding sites in general and can therefore not be used as a 
tool to differentiate between protein kinases or ATPases. 
Ouabain was found to have no inhibitory effect on the ATP -
binding 46 kD polypeptide. 
The effect of colchicine on N3ATP labelling of the 46 kD 
protein was found to be very similar to that reported by 
Agutter et al. (1979a). A low level of inhibition of N3ATP -
binding by concentrations of colchicine demonstrated to 
inhibit nucleocytoplasmic rnRNA transport (Agutter and 
Suckling, 1982) is in keeping with previoui observations 
(Agutter et al., 1979a & b). Also, the isolated nuclear 
envelope NTPase has been shown to be unaffected by 
colchicine (Schroder et al., 1986), indicating that this 
inhibitor does not directly interact with the NTPase. A 
model for colchicines actions in the inhibition of 
nucleocytoplasmic mRNA efflux has been postulated by Agutter 
and Suckling (1982) in which colchicine does not interact 
with the NTPase, but rather with a protein in the pore 
lamina complex. 
The GTP competition result (figure 3.5) is in keeping with 
the report of Rubins et al. (1990) indicating that the ATP -
binding of the 46 kD polypeptide is inhibited only by ATP 
and not GTP. Parenthetically, the 55 kD doublet of the 
nuclear envelope is not ATP specific. This experimental 
agreement reinforces the 'conclusion that the 46 kD 
polypeptide investigated in this thesis is indeed the NTPase 
putatively involved in nucleocytoplasmic translocation of 
mRNA. 
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The postulated role of the 46 kD polypeptide as the specific 
energy generator for mRNA nucleocytoplasmic translocation in 
the rat liver (see 4.1) is difficult to reconcile with its 
widespread occurrence. These findings call into question the 
assumption that this protein is a specific nuclear envelope 
/nuclear matrix component {Clawson et al., 1984; Clawson et 
al., 1986; Clawson et al., 1985), facilitating 
nucleocytoplasmic translocation of mRNA. I have demonstrated 
that it is found in diverse cellular membranes. Thus, this 
polypeptide may rather be a general ATPase, and as such, a 
component in an energy generating system possibly resulting, 
when it is located in the nuclear envelope, in the 
facilitation of mRNA efflux. 
The other alternative, that the 46 kD protein is not an 
ATPase but rather an ATP binding protein of a different 
nature, is open to investigation. A possible candidate may 
be the ubiquitous G actin. However, it has a molecular 
weight of only 42 kD and an isoelectric point of 5.8 versus 
5.2 of the protein under investigation here (Elzinga et al, 
1973). Furthermore, the monomeric G actin exchanges ATP only 
' 
once its metal binding site is free - if occupied by ca2+ or 
Mg2+ the ATP is fixed {Strezelecka-Golaszewska, 1973). Under 
the conditions chosen in my experiments i.e. 5 or 10 mM Mg2+ 
all binding sites in the putatively present G actin should 
be fully occupied by metal, making the observed exchange 
against azido ATP unlikely. In addition, G actin is only 
partially saturated at 200 µM ATP, whereas the protein 
described here has its ATP binding site occupied at 10 µM. 
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Chapter 4 
The In Vitro Effects of Insulin on the ATP - Binding and 
Phosphorylation of Rat Liver Nuclear Envelope Proteins 
4.1. Introduction 
There is evidence from in vitro studies that intracellular 
insulin binding leads to a decrease in the phosphorylation 
of nuclear envelope protein (Purrello et al., 1983); the 
stimulation of nuclear envelope NTPase activity (Purrello et 
al., 1982); and·the stimulation of mRNA efflux (Bolander et 
al., 1981; Purrello et al., 1983). The concomitant increase 
in dephosphorylation has been interpreted to be the result 
of a stimulation of endogenous nuclear envelope phosphatases 
and not an inhibition of protein kinases (Purrello et al., 
1983) • 
mRNA efflux is an ATP - dependent process (Ishikawa et al., 
1978), the ATP being hydrolysed by the nuclear envelope 
NTPase (Clawson et al., 1980a & b; Agutter, 1979a & b; 
Agutter et al., 1976). The NTPase putatively responsible for 
mRNA efflux is thought to be a nuclear pore complex 
component, an almost inevitable location for an enzyme 
involved in nucleocytoplasmic translocation. 
That the stimulation of nuclear envelope dephosphorylation, 
NTPase activity, and mRNA efflux, are all maximal at an 
insulin concentration of .10 pM, has suggested a link between 
all these phenomena and has led to the development of a 
model for the direct regulation of the functional state of 
nuclear envelope proteins and mRNA efflux by insulin 
(Purrello et al., 1983). Briefly, this model proposes that 
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nuclear - bound insulin stimulates nuclear envelope 
phosphatases, which in turn· dephosphorylate the NTPase. The 
activated NTPase is then capable of increased ATP 
hydrolysis, thus providing the required energy for mRNA 
<]:·--· 1 .... . ' 
efflux. This_regulation of mRNA efflux by insulin has been 
extensively reviewed (Goldfine et al., 1982a & b; Goldfine 
et al., 1985) • 
. .f .. ·-
This empirical model is based on 3 separate observations 
i.e. the stimulation of dephosphorylation, NTPase activity, 
and mRNA efflux. To obtain direct evidence of the modulation 
of the NTPase activity by insulin, purified rat liver 
nuclear envelopes were labelled with (~32PJN3ATP, after 
preincubation with varying concentrations of insulin. Any 
increase in ATP - binding, especially in an insulin 
concentration dependent manner, would represent, to my 
knowledge; the first unequivocal evidence of a direct effect 
of insulin on this NTPase activity. This chapter summarises 
the results of such an investigation. 
4.2. Results 
Rat liver nuclear envelopes isolated by the method of 
Kaufman et al. (1983) were preincubated with varying 
concentrations of insulin, prior to incubation with (~32p]­
N3ATP. The labelled membrane fractions were then subjected 
to SDS PAGE and autoradiography. A typical result is 
presented in figure 4.1 (A - D). 
Other conditions of insulin preincubation time, insulin 
concentration, and (~32PJN3ATP incubations times were used, 
with no effect on the labelling pattern, either 
quantitatively or qualitatively (results not shown). The 
insulin preincubation times in figure 4.1 i.e. 5 minutes and 
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Fi~ure 4.1. The Effect of Insulin on the Phosphorylation And 
[~ 2P]N3ATP - Binding Pattern in Isolated Rat Liver Nuclear 
Envelopes. 
Rat liver nuclear envelope (150 µg in 250 µl of incubation 
medium), isolated by the method of Kaufman et al.j1983) 
were incubated for 2 minutes with fr32p]ATP or fr 2PJN3ATP (made to 5 µM with cold ATP) after preincubation with 
varying concentrations of cold insulin for 30 minutes or 5 
minutes. After incubation, the phosphorylation reactions 
were terminated by pelleting the membranes and immediately 
solubilising in 70 µl of sample application buffer. The 
N3ATP incubations were terminated by pelleting and washing 
the envelopes with cold incubation medium (3x). These 
envelopes were then resuspended in incubation medium, 
irradiated (see 6.3.2.) and solubilised in 70 µl sample 
application buffer. 
A: coomassie pattern of envelopes preincubated with insulin 
for 30 minutes. 
B: Autoradiogram of gel A. 
C: Coomassie pattern of envelopes preincubated with insulin 
for 5 minutes. 
D: Autoradiogram of gel c. 
Lanes 1 - 5: nuclear envelopes incubated with [r32p]ATP 
Lanes 6 - 10: nuclear envelopes incubated with [r32p]N3ATP. 
Lanes: 1 & 6) no insulin; 2 & 7) 10 pM insulin; 3 & 8) 100 
pM insulin 4 & 9) 10 nM insulin; 5 & 10) 100 nM insulin. 
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30 minutes were chosen to represent short and medium term 
effects of insulin, respectively. 
It can be concluded from the results, that under these 
experimental conditions, insulin has no direct in vitro 
effect on either the N3ATP labelling or phosphorylation 
pattern in rat liver nuclear envelopes. The slight 
variations in labelling intensity are due to small 
differences in the quantity of material loaded onto the' 
gels, and does not represent an insulin concentration -
dependent change. 
4.3. Discussion 
The results shown in figure 4.1. provide no evidence that 
insulin directly modulates nuclear envelope phosphorylation 
activity nor increases ATP - binding by the NTPase. This 
does not, however, preclude i s~lin stimulation of NTPase 
activity (section 4.1). The~~odei of insulin action on the 
nuclear envelope is based on 3 independent observations of 
insulin effect i.e. a general decrease in phosphorylated 
proteins due to a stimulation of phosphatase activity 
(Purrello et al., 1983}; 'an increase in ATP hydrolysis due 
to an increase in Vmax (Purrello et al., 1982}; and an 
increase in mRNA efflux (Purrello et al., 1983; Bolander et 
al., 1981).It is generally accepted that nuclear envelope 
NTPase activity is due to a single class of protein and this 
is borne out by the labelling patterns obtained in this 
investigation (figure 3.2.). Histochemical studies (Clawson 
et al., 1980a} suggest that the NTPase may be evenly 
distributed over the entire nuclear envelope. The NTPase 
involved in the mRNA efflux mechanism, situated at the 
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Figure 4.2 The Effect of Streptozotocin OD the Protein 
Profile and Enzymatic Activity of Rat Liver Nuclear 
Envelope. 
2. 
A: Nuclear envelopes from normal (1 and 3) and 
streptozotocin - treated rats (2 and 4) were isolated by the 
methods of Bornens and Courvalin (1978) (1 and 2) and 
Kaufmann et al. (1983) (3 and 4). Approximately 150 µg of 
each fraction was subjected to one dimensional SDS PAGE as 
described in (6.4.7.3). 
B: Nuclear envelopes isolated by the method of Kaufmann et 
al. (1983) from normal (1) and streptozotocin treated rats 
(2) were resuspended in 250 µ1 incubation medium and 
incubated with 10 µH [-y32P]ATP as described in 6.3.2. The 
labelled membranes were subjected to one dimensional SDS 
PAGE and autoradiography (6.4.7.3). 
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nuclear pore complex, may thus represent only a fraction of 
the total NTPase content. Thus any insulin - induced change 
in ATP - binding in the pore complex - located fraction of 
the NTPase may be masked by the overwhelming presence of the 
non - pore complex associated NTPase. This could explain the 
observation that insulin stimulates NTPase activity, as 
assayed by hydrolysis of ATP (Purrello et al., 1983), but 
not ATP - binding (figure 4.1.). The primary target of 
insulin would, however, have to be sought in a nuclear pore 
- specific mediator which activates only the pore located 
NTPase. Accepting such an explanation would make the 
findings in figure 4.1 reconcilable with the model proposed 
by Purrello et al. (1983). However, there is no evidence at 
this stage that insulin interacts with any of the core 
complex components. 
The degree of stimulation may also be insufficient to be 
detected by the direct labelling method. A concentration of 
10 pM insulin has been demonstrated to stimulate the NTPase 
activity by approximately only 30% (Purrello et al., 1982). 
If this level of stimulation is accepted as reality, then 
the lack of an insulin effect may indicate that insulin 
affects the NTPase at the post ATP - binding stage i.e. Vmax 
is increased due to an increase in the rate of hydrolysis or 
an increase in ADP - dissociation. These could arise from 
subtle conformational changes due to insulin induced 
phosphorylation / _dephosphorylation of specific residues. In 
either case, there is a strong possibility that this would 
not result in a detectable change in ATP - binding. 
The autoradiograph of the N3ATP - binding profile (figure 
4.1) has been overexposed and printed on low contrast 
photographic paper in order to accentuate any differences in 
the 46 kD band. A consequence of this is the pronounced 
background, indicting that the (132P]N3ATP is being utilised 
as a phosphate donor by endogenous protein kinases. This is 
in accordance with previous findings (Sabbatini & von Holt, 
1987) . 
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The lack of discernable stimuiation of dephosphorylation by 
insulin (figure 4.1. B & D, lanes 1 - 5) is not in 
accordance with the findings of Purrello et al. (1983) who 
reported a 40% decrease in phosphorylated proteins with 10 
pM insulin, and may represent differences in methodology. 
These authors used nuclear envelopes isolated by the method 
of Monneron et al. (1972) from streptozotocin treated rats. 
This isolation method produces nuclear envelopes high in the 
46 kD NTPase activity but relatively low in phosphorylation 
activity (figure 3.1.). The experiments reported here 
utilised nuclear envelopes isolated by the method of 
Kaufmann et al. (1983) from untreated, healthy rats. These 
en~elopes display a slightly different phosphorylation 
pattern (figure 3.1.). More importantly, these envelopes 
were isolated from non - streptozotocin treated rats. I have 
executed intensive trials involving this treatment in order 
to obtain envelopes with reproducible enzymatic pattern. In 
the majority of animals the livers were very enlarged with 
mottled lipid deposits all over the tissue, giving the 
morphological impression of a generally toxic liver damage. 
Rather than use such damaged tissue, it was deemed 
preferable to investigate "non-diabetic" rats at higher 
insulin concentrations (figure 4.1.). The result represented 
in figure 4.2 is of interest since it clearly illustrates 
that despite very similar Coomassie patterns, the N3ATP -
binding profile is quantitatively very different, possibly 
indicative of the diseased state of the tissue from 
streptozotocin - treated rats. To accept these differences 
as a specific result of insulin deficiency would have 
required investigations beyond the scope of my project. 
In conclusion, the results reported here show no effect of 
insulin on ATP - binding in liver cell nuclei from rats not 
poisoned with streptozotocin. 
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Chapter 5 
Discussion And summary 
There are a number of experimental results which have been 
interpreted to demonstrate direct control of nuclear 
envelope biological activity by insulin, for example, the 
stimulation of phosphatase (Purrello et al., 1983) and 
NTPase activity (Purrello et al., 1982). At the insulin 
concentration at which this stimuiation is maximal {10 pM), 
mRNA efflux from isolated nuclei is also maximally 
stimulated {Purrello et al., 1983). Thus a model for the 
direct modulation of mRNA efflux by insulin has been 
formulated, with the nuclear envelope NTPase the energiser 
of this process (Purrello et al., 1983, Goldfine et al., 
1982a & b). 
Presented in this thesis are the results of my investigation 
into the putative direct modulation by insulin of mRNA 
efflux from the nucleus, thought to be facilitated through 
an effect on nuclear phosphatases. The principal focus of 
this investigation has been the determination of the direct 
biological effects of insulin on nuclear envelope NTPases in 
vitro. This target has been chosen since it is the NTPase 
which is thought to provide the motive force for this mRNA 
efflux. Much of the present evidence in the literature is 
based on the measurement of the overall rate of in vitro 
hydrolysis of (-y32p]ATP by NTPases of purified nuclear 
envelopes incubated with insulin {Purrello et al., 1982). My 
objective has been to demonstrate the presence of ATP -
\ 
binding membrane - associated polypeptides, as the mediators 
of such an ATP hydrolysis. Furthermore, the investigations 
were aimed at ascertaining whether insulin directly affects 
the ATP - binding by certain of these putative NTPases. 
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In addition, I have attempted to identify changes in the 
phosphorylation pattern of nuclear envelope polypeptides as 
a result of insulin .. The second focus of this investigation 
has been the probing for a specific insulin docking 
polypeptide in nuclear envelopes. This is important since 
one of the first stages of a direct insulin effect on the 
nucleus must be binding to a nuclear envelope receptor. 
Demonstration of the internalisation of the insulin -
receptor complex and the specificty of in vitro binding to 
the nuclear envelope has been extensively reported in the 
literature (see 1.2.1). The kinetics of this binding has 
been demonstrated to differ from that of plasma membrane 
binding, thus implying that the specific nuclear envelope 
receptor differs from that of the the plasma membrane. To 
date, many of the investigations have focussed on kinetic 
studies of the association of 125r - labelled insulin with 
isolated nuclei (Goldfine et al., 1982a & b; Goldfine 1987) 
or morphological studies employing insulin conjugated to 
electron - dense or fluorescent moieties (Carpentier et al., 
1979, Schlesinger et al., 1978). These experiments have 
yielded valuable information but have not identified 
specific nuclear insulin - docking polypeptides in situ. The 
direct visualisation and identification of a nuclear 
envelope - associated receptor would corroborate the 
findings of Wong et al. (1988) who isolated a protein very 
similar to the plasma membrane receptor, from nuclei. The 
demonstration of a docking protein in intact nuclei i.e. 
still associated with a membrane structure, would constitute 
strong support for the view that some of the biological 
effects of insulin are the result of a direct interaction 
with the nucleus. 
To accomplish the objective of probing for insulin and ATP -
binding polypeptides, use has been made of insulin and ATP 
analogues which can be covalently attached to those 
polypeptides with which they specifically interact, thereby 
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specifically labelling them. 
To facilitate this it has been necessary to develop 
protocols for the synthesis of carrier - free, radioactive 
and photoactivatable analogues of both insulin and ATP. 
These have been fully characterised and used to probe for 
their respective binding polypeptides and ultimately to 
determine whether the putative ATP - binding proteins are 
directly modulated by insulin in vitro. 
An in depth discussion of the synthesis and use of these 
analogues has been made (see sections 1.1.3, 1.2.3, 2.3, 
3.3, 4.3), but various aspects require further mention. 
The enzymatic protocol for the synthesis of [l32P]N3ATP 
represents an innovative approach to the synthesis of 
photoactivatable, radioactive ATP analogues (Sabbatini & von 
Holt., 1987). This protocol allows for the synthesis, in 
less than 60 minutes, of carrier - free [l32PJN3ATP
0
in a 
single step without the need for extensive purification. 
This is a significant advantage over the exchange reaction 
of Glynn and Chappel (1964) or the method developed by 
Potter and Haley (1983) which requires subsequent more 
complex purification of the product. The advantage of this 
' 
enzymatic method over the chemical protocol (Czarnecki et 
al., 1979), with its low yield, long reaction time, and 
potentially harmful starting reagents, is even more marked. 
The resultant product has been characterised and shown to be 
fully biologically active (see 2.3). This has enabled its 
use to probe for ATP binding proteins in intracellular 
membrane structures (see 3.2) and glucocorticoid receptor 
extracts (see appendix 1). 
The mapping studies of the intracellular ATP - Ptnding 
polypeptides proved both fruitful and interesting. The key 
finding is the widespread occurrence of a 46 kD ATP -
binding polypeptide, having very similar properties to those 
attributed to the NTPase involved in mRNA efflux from the 
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nucleus. It is generally accepted that the NTPase activity 
of the nuclear envelope is due to a single class of NTPase 
and that this activity resides in the nuclear pore complex 
(Purrello et al., 1983). The fact that this polypeptide is 
present in such diverse membrane structures as mitochondria, 
nuclear envelopes, plasma membrane and even chromosomes (see 
3.2) is interesting and negates the assumption that it is a 
specific nuclear envelope component. Its widespread 
occurrence indicates that it may be a general membrane -
associated NTPase, and that its putative involvement in the 
nucleocytoplasmic translocation of mRNA may be due to its 
association, in the nuclear pore complex, with other 
possible insulin modulated components. One such component 
may be the phosphatase which is postulated to 
dephosphorylate the NTPase, thus activating it. This 
phosphatase may be specific to the nuclear envelope, since 
it has been demonstrated that there is no insulin stimulated 
dephosphorylation in plasma membranes (Purrello et al., 
1983). Such a nuclear envelope specificity of the 
phosphatase would permit a general cellular NTPase, such as 
the 46 kD polypeptide, to become indirectly insulin -
modulated when associated with the n~clear envelope. This 
widespread occurrence of the NTPase may also indicate that 
it does not possess the mRNA - binding site, since this 
would be evolutionarily "wasteful" from a complexity point 
of view. Rather, it may be that the NTPase is closely 
associated with the phosphatase and a mRNA - binding protein 
in the nuclear pore complex. The model could be modified in 
that the activation of the phosphatase by insulin leads to 
the dephosphorylation, and thus, activation of both the 
NTPase and the mRNA binding polypeptide. Alternatively, 
activation of the NTPase may result in conformational 
changes in its structure, with a secondary effect on mRNA -
binding binding site of the closely associated polypeptide. 
This would not conflict with the proposal that mRNA 
activates the NTPase activity (Purrello et al, 1982). 
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The investigation of the direct effects of insulin on the 
ATP - binding by the NTPase did not reveal any increase in 
ATP - binding as a result of preincubation with insulin 
(figure 4.1). Thus, at face value it appears that insulin 
has no effects on the NTPase. However, if specific nuclear 
pore complex association of a NTPase - modulating 
phosphatase, which in turn is the insulin - sensitive 
target, is postulated it is feasable to argue that my 
findings do not contradict the model of insulin action on 
the nucleus. However, it cannot be postulated that the 
nuclear pore complex - associated NTPase differs from that 
dispersed throughout the nuclear envelope, since there is 
evidence that the NTPase activity is due to a single class 
of NTPase. Though the experiments presented do not disprove 
the validity of the model proposed to explain effects of 
insulin on the nucleus, they have not yielded any supporting 
evidence. Equally, the general phosphorylation pattern from 
normal rats is not influenced by exposure of the nuclei to 
insulin in vitro. 
The protocol for the synthesis of the insulin analogue 
represents an improvem~nt on existing protocols, since only 
the SASD moiety is iodinated and the coupling of this 
carrier - free moiety is only to the N - terminal of the 
insulin molecule only. The avoidance of the iodination of 
the insulin molecule and the minimisation of steric 
hindrance by the SASD moeity, by coupling to only one amino 
group, ensure that adverse effects on the biological 
activity are minimised. That this is so, is clearly 
demonstrated by the characterisation studies, both in situ 
and in vivo, which clearly demonstrate that the analogue 
possesses a biologi9al activity very similar to that of 
native insulin (see 1.1.2). The analogue binds specifically 
to the plasma membrane receptor (figure 1.1.15); induces 
hypoglycaemia in mice to a level comparable with that of 
native .insulin (figure 1.1.16); and induces specific genes 
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in a hepatoma cell line, al~o-at. levels similar to those for 
native insulin (figure 1.1.17). It can therefore be 
concluded that this protocol yields a defined and well 
characterised product. Considering the bulkiness of the SASD 
moeity and the number of manipulations involved in the 
synthesis, the resultant high biological activity of the 
final product is surprising. 
Of interest are the results of the probing for intracellular 
insulin - docking polypeptide(s). The positive 
identification of the insulin receptor in the plasma 
membrane of intact hepatoma cells is in keeping with the 
gene induction studies (figure 1.1.15) and the literature. 
The presence of a 60 kD insulin - binding polypeptide in rat 
liver nuclear envelope is of special interest and could, 
assuming it not to be a degradation product of a larger 
molecule, represent an important interface for the direct 
modulation of nuclear activity by insulin. As discussed in 
1.2.3, this finding need not represent a contradiction of 
the findings of Wong et al. (1988) on the presence of a 
receptor vi!tually identical to that in the plasma membrane. 
Rather, such a polypeptide may play a mediating role in that 
it limits the initially receptor - bound insulin to a not 
yet identified enzyme, thereby initiating a series of 
specific events. Alternativelyi certain effects of insulin 
may be dependent on binding to both the 60 kD and 130 kD 
nuclear envelope receptors, either sequentially or 
concomitantly. The alternative may also apply, that is, the 
plasma membrane insulin receptor constitutes a shuttling 
protein between the cell periphery and the nucleus, in much 
the sam~ way as the cytoplasmic glucocoticoid receptor and 
the observed 60 kD binding polypetide may represent a 
proteolytic breakdown product of the shuttling protein. 
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In summary, novel protocols have been developed for the 
synthesis of carrier - free, photoactivatable ATP and 
insulin analogues. These have been successfully employed to 
identify ATP as well as insulin - binding polypeptides in 
various intracellular membrane structures. In applying these 
tools to test the model of insulin action promoted in the 
literature by a number of authors {see Fig 1.1), I could not 
find in my experiments evidence in direct support of this 
hypothesis. The major findings of this investigation has 
been the ubiquitous occurrence of the 46 kD ATP - binding 
protein and the presence, in the nuclear envelope, of an 
approximately 60 kD insulin - binding polypeptide. 
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Chapter 6 
Methods and Materials 
6.1 Isolation Procedures 
6.1.1 Rat Liver Nuclei 
Rat liver nuclei were isolated by the method of Blobel and 
Potter (1966). Rats were starved overnight and sacrificed by 
cervical dislocation and immediate exsanguination. The 
excised livers were trimmed of connective tissue and 
weighed. After finely chopping, the livers were homogenised 
in two volumes of 0,25 M sucrose / TKM (0,05 M Tris-HCl, 
pH7,5; 0,025 M KCl; 0,0015 M MgC12 ) using a glass / teflon 
rotary homogeniser. The homogenate was filtered through one 
layer and then four layers of cheesecloth and the resulting 
filtrate spun at x750g for 10 minutes. The supernatant was 
then decanted and the loose pellet resusp~nded in 9 - 10 
volumes 2,3 M sucrose / TKM. This suspension was centrifuged 
at x39000g for 45 minutes. The resultant pellet of purified 
nuclei were resuspended in 2,3 M sucrose / TKM and stored 
under liquid nitrogen. 
101 
6.1.2 Rat Liver Nuclear Envelope. 
6.1.2.1 Method of Bornens and Courvalin (1978) 
Nuclei were suspended in 0,25 M sucrose / 2 mM sodium 
phosphate, pH 7,85 to a protein concentration of 1,5 mg/ 
ml. While gently stirring, heparin was slowly added to a 
final heparin: DNA ratio of 1 (w / w}. After stirring for 
60 minutes the solution was centrifuged at x48000g for 45 
minutes. The crude nuclear envelope pellet was resuspended 
in a minimum volume of 0,25 M sucrose / 2 mM sodium 
phosphate, pH 7.85 by gently homogenising in a 2 ml glass 
homogeniser. This suspension was then layered over a 25 -
50% sucrose / 2 mM sodium phosphate, pH 7.85 continious 
gradient and centrifuged for 180 minutes at x230000g. The 
purified nuclear envelope banding at approximately 37% was 
fractionated and stored under liquid nitrogen. 
6.1.2.2 Method of Kaufmann et al. (1983) 
Nuclei were suspended in 0,25 M sucrose / TMP (50 mM Tris-
HCl, pH 7.4; 5 mM MgC12 ; 1 mM PMSF ) to a concentration of 
5x108 nuclei / ml. The nuclei were incubated with DNase 1 
and RNase A (1 mg / 4 ml} for 60 minutes and then 
centrifuged at x800g for 10 minutes. 
The resultant pellet was resuspended in TMP to a 
concentration as above and 4 volumes of 2 M NaCl, TMP was 
added dropwise with stirring. Mercaptoethanol was added to a 
final concentration of 1% and the solution was· allowed to 
incubate for 15 minutes. The solution was centrifuged at 
xl600g for 30 minutes and the resultant pellet further 
purified by reextracting with 2 M NaCl / TMP (minus 
mercaptoethanol). 
The isolated material was stored under liquid nitrogen. 
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6.1.2.3 Method of Monneron et.al. (1972) 
The nuclear pellet (60 mg DNA) was resuspended in 25 drops 
of glycerol followed by 24 ml of 1,8 M sucrose / TM (50 mM 
Tris-HCl, pH 7.5; 500 mM MgCl2) and mixed vigorously for 60 
seconds using a vortex mixer. The viscous solution was then 
centrifuged at xlOOOg for 5 minutes and 3 ml aliquots of the 
resultant supernatants were placed in rotor tubes. Over 
these aliquots were poured 20 - 50% sucrose / TM gradients 
and the samples were then centrifuged at x230000g for 90 
minutes in a SW 40 rotor. 
The resultant discrete bands were pooled and stored under 
liquid nitrogen. 
6.1.2.4 Method of Kay et al. (1972) 
Purified nuclei were suspended in 0,1 mM MgCl2 at a 
concentration of 7 mg DNA / ml. To this was added DNase 1 
{10 µg / ml) and 4 volumes of 0,3 M sucrose / TMM (10 mM 
Tris-HCl, pH 8.5; 0,1 mM MgC1 2 ; 5 mM mercaptoethanol) and 
the solution was then incubated for 15 minutes at 22°C. 
The incubation was terminated by the addition of an equal 
volume of ice cold water followed by centrifugation at 
x38000g for 15 minutes. 
The resultant pellet was further purified by repeating the 
DNase 1 digestion but this time in 0,3 M sucrose / TMM, pH 
7.4. The nuclear envelope was stored under liquid nitrogen. 
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6.1.3 Rat Liver Plasma Membrane 
Plasma membranes were isolated essentially as described by 
Aronson and Touster {1974). Rats were starved overnight and 
sacrificed by cervical dislocation and exsanguination. The 
livers were immediately perfused with 50 ml of 0,25 M 
sucrose / 5 mM Tris-HCl, pH 8.0 and trimmed of connective 
tissue prior to being finely chopped up. The liver was 
homogenised in 3 volumes of perfusion buff er per gram of 
liver in a teflon / glass Potter homogeniser. The homogenate 
was filtered through four layers of cheesecloth and then 
centrifuged at xlOOOg for 10 minutes. 
The resultant supernatant was spun at x33000g for 8 minutes 
and the pellet retained. The supernatant was then 
centrifuged at x78000g for 100 minutes and the resultant 
pellet homogenised with 3 volumes of 57% sucrose / 5 mM 
Tris-HCl, pH 8.0 (w / w) per gram of liver using a Dounce 
homogeniser. Twelve ml of this homogenate was placed in a 
rotor tube and overlayered with 15 ml of 34% sucrose / 5 mM 
Tris-HCl, pH 8.0 (w / w). The tube was then topped with 0,25 
M sucrose / 5 mM Tris-HCl, pH 8.0. The samples were 
centrifuged at xlOOOOOg for 16 hours in a SW 28 rotor. 
The plasma membrane fraction was obtained at the 34% / 0,25 
M sucrose interface. 
Plasma membranes were also obtained from the nuclear pellet 
by resuspending the pellet in 3 volumes of 0.25 M sucrose 
and centrifuging at x33000g for 10 minutes. The packed 
nuclei were then resuspended in 1.5 volumes 57% sucrose per 
gram of liver and approximately 15 ml placed in the bottom 
of a SW 28 tube. This was overlayered with 15 ml of 37.2% 
sucrose and finally 0.25 M sucrose. The samples· were then 
subjected to centrifugati'on at xlOOOOOg for 16 hours. The 
plasma membrane fraction at the 37.2 / 0.25 M sucrose 
interface was removed. 
All plasma membrane fractions were pelleted, resuspended in 
57% sucrose, and stored under liquid nitrogen. 
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6.1.4 Rat Liver Mitochondria 
r 
Mitochondrial fractions were isolated essentially as 
described by Aronson and Touster (1974) for the isolation of 
plasma membrane (7.1.4). The mitochondrial pellet obtained 
after the x33000g spin was resuspended in o~25 M sucrose and 
recentrifuged. The resultant peliet was stored in 57% 
sucrose under liquid nitrogen. 
6.1.S Friend Cell Nuclei / Hepatoma Nuclei 
Nuclei were isolated essentially either as described by 
Smith et al. (1988) or Gasser and Laemmli (1987). Using the 
former method, cells were pelleted and rinsed twice in 
Dulbecco's phosphate buffered saline (DPBSA) before 
resuspending in DPBSA at a concentration of 1x108 cells / 20 
ml. The cell solution was vortexed with melittin (1 µg / 
1x106 cells), and then centrifuged on a bench top centrifuge 
for 5 minutes. 
The pellet was resuspended in 10 ml of 0,34 M sucrose / TKM 
and homogenised with 5 strokes of a tight - fitting Dounce. 
To the homogenised solution was added 9 volumes of 2,3 M 
sucrose / TKM and the solution centrifuged at x39000g for 45 
minutes. 
The alternative method used was that based on the report of 
Gasser and Laemmli (1987) for the isolation of metaphase 
chromosomes, with the obvious exception that the first 
Ficoll paque gradient to separate out metaphase cells is 
omitted. Briefly, cells were pelleted and resuspended in 20 
ml solution 1* and pelleted at xsoog for 5 min~tes. This 
hypotonic procedure was repeated twice at 22°C and the 
pellet then resuspended in 20 ml of ice-cold solution 2**. 
The cells were then homogenised until microscopic 
investigation revealed that the vast majority of the cells 
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were lysed. The homogenate was then centrifuged at xlOOOg 
for 10 minutes and the resultant pellet resuspended in 2 M 
sucrose in solution 2. This suspension was then centrifuged 
x33000g for 45 minutes and the resultant pellet gently 
rehomogenised in 6 ml of solution 2. Two ml of this was 
applied to a percoll gradient (4.5 ml percoll; 2 ml 70% 
glycerol; 0.5 ml buffer B stock (x20); and 1 ml solution 
3***) and centrifuged at 25000 r.p.m. for 30 minutes in a 75 
Ti rotor. 
Nuclei were stored under liquid nitrogen. 
100 mM Tris-HCl, pH 7.4; 400 mM KCl; 400 mM EDTA; 5 mM 
spermidine. 
* 7.5 mM Tris-HCl, pH 7.4; 40 mM KCl; 1 mM EDTA, 0.1 mM 
spermine; 0.25 mM spermidine; 1% TDG; 0.1 mM PMSF. 
** 15 mM Tris-HCl, pH 7.4; 80 mM KCl; 2 mM EDTA; 0.2 mM 
spermine; 0.5 mM spermidine; 1% TDG; 0.1 mM PMSF. 
*** 20 mM spermine; 8 mM spermidine 
6.1.6. The Isolation Of Metaphase Chromosomes. 
All solutions for the isolation of metaphase chromosomes are 
as described in 6.1.7. 
Metaphase arrested Friend cells were separated from non-
metaphase cells on a Ficoll Paque gradient, the metaphase 
cells banding at 75%. 
The metaphase cells were resuspended in 20 ml of solution 1 
and gently pelleted for 5 minutes. This hypotonic washing 
step was repeated twice at room temperature. The washed 
cells were then resuspended in ice cold solution 2 and 
homogenised until the bulk of the cells were lysed (checked 
microscopically). The homogenate was then centrifuged at 
xl200g for 5 minutes and the pellet resuspended in 2 ml of 
solution 2 . The resuspended pellet was then added to 8 ml 
of a Percoll solution (4.5 ml Percoll; 2 ml of 70% glycerol; 
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0.5 ml buffer B; and 1 ml solution 3) and centrifuged at 
25000 r.p.m. for 30 minutes in a 75 Ti rotor. The 
chromosomes banded in the second layer. 
6.1.7 The Isolation of Crude Rat Liver Nuclear Envelope 
Insu1in Receptors by Affinity Chromatography. 
crude rat liver nuclear envelope insulin receptor extracts 
were isolated as described by Wong et al. {1988). 
Essentially, nuclei {3 mg / ml) isolated by the method of 
Blobel and Potter {1966), were incubated at 22°C in 0.25 M 
sucrose, 2% Triton LE, 0.2 mM PMSF, and 50 mM Tris, pH 7.4. 
Triton LE was used due to its low uv absorbance - important.· 
when monitoring the effectiveness of washing away non -
bound proteins from the affinity column. After 45 minutes, 
20 ml of the solubilised receptor mixture was added to a 40 
ml centrifuge tube containing 10 ml of wheat germ agglutinin 
- derivatised agarose {binding capacity 5 mg RNase / 3 ml 
matrix). The tube was sealed and incubation allowed to 
proceed for 2 hours at 22°C with constant agitation. The 
mixture was then poured as a column and extensively washed 
with the solubilisation buffer. The washings were 
continuously monitored spectrophotometrically and when a 
stable baseline was achieved, the column was washed with the 
receptor elution buffer (0.3 MN - acetylglucosamine, 150 mM 
NaCl, 0.1% Nonidet LE, 0.1 mM PMSF, and 50 mM Tris - HCl, pH 
7.6. Fractions of 200 µl were collected and the relevant 
fractions pooled. 
The wheat germ agglutinin - derivatised agarose was kindly 
prepared by Dr. Robert Warren. 
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6.2 Preparative Techniques 
6.2.1 The Enzymatic synthesis of 8-Azidoadenosine S-[732p] 
Triphosphate 
The [~32P]N3ATP was synthesised according to the method of 
Sabbatini and von Holt (1987). 
All procedures were performed in subdued light. 
To 40 µl of reagent mixture (125 mM Tris-HCl, pH9.0; 30 mM 
MgC1 2 ; 4,5 mM spermine; 0,3 mM L-a-glycerolphosphate; 0,5 mM 
NAD; 0.125 mM N3ADP; and 2,5 mM pyruvate) was added 20 µl of 
the glycolytic enzyme mixture (0,34 U glycerolphosphate 
dehydrogenase; 0,1 U triosephosphate isomerase; 0,16 U 
glyceraldehyde-3-phosphate dehydrogenase; 0,09 U 3-
phosphoglycerate kinase, and 1,9 u lactate dehydrogenase in 
50 mM Tris-HCl,pH 9.0 and 2 mM B-mercaptoethanol). To this 
mixture was added 50 µl 32p orthophosphate and the mixture 
was incubated for 30 minutes. The degree of incorporation.of 
orthophosphate into N3ADP was determined by an activated 
charcoal assay (see 6.4.11.). The reaction was terminated by 
the addition of an equal volume of Tris - saturated phenol, 
pH 8.0. The aqueous phase was then extracted with chloroform 
and the resultant product stored at -20°c .after analysis by 
TLC (see 6.4.13.). 
6.2.2 The Preparation of the Diboc -.Insulin Derivative, N-
(t-Boc-GJyA1, N-t-Boc-LysB29Jznsulin 
The method employed was esse~tially as that described by 
Grant and von Holt (1987). 
Batches of 228 mg (40 µmoles) of insulin were dissolved in 
2,4 ml of 75% pyridine in water and to this was added 19,6 
108 
mg (80 µmoles) of BOPA in 0,6.ml.of DMF containing 200 µl of 
1 N sodium bicarbonate. The· reaction was allowed to proceed 
for 16 hours at 22°c and terminated by the addition of 16 ml 
of 10% acetic acid. The precipitate was pelleted by 
centrifugation on a bench top centrifuge and the supernatant 
discarded. The pellet containing mono -, di -, and tri - boc 
derivatives was solubilised in acetonitrile and subjected to 
reverse phase HPLC on a µ - Bondapak Cl8 Radial Pak column 
using the following gradient solutions and profile: 
solution A: 
solution B: 
Gradient profile: 
0,05% TFA 
70% acetonitrile in 0,05% TFA 
0% B for lOminutes 
O - 35% B over 5 minutes 
35 - 45% B over 30 minutes 
45 - 100% B over 5 minutes 
100 - 0% B over 10 minutes 
The flow rate was 1 ml / minute and samples were collected 
as 1 ml aliquots. 
The fractions were lyophilised and their identity as di -
boc insulin confirmed by acid - urea PAGE. 
The sample's identity as N-t-boc gly Al, N-t-boc lys B29 
insulin was confirmed by amino acid sequencing, the sole 
product of the first cleavage step being phe. 
6.2.3 The Synthesis of SASD - Derivatised Insulin 
Diboc insulin refers to N-t-boc gly Al, N-t-boc lys B29 
insulin. 
The reaction was performed in in a 2 ml stoppered, silanised 
glass vessel. 
All procedures involving SASD were performed under stringent 
red light conditions to avoid photoactivation of the azido 
moiety. 
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Diboc insulin (200 µg ) was diss9lved in 120 µl of reaction 
buffer (300 parts DMSO : 20 parts triethylamine) and to this 
was added 50 µg of SASD dissolved in 5 µl DMSO. The reaction 
vessel was flushed with nitrogen and firmly stoppered. The 
reaction was allowed to proceed for 16 hours at 37°C, after 
'· 
which the buffer was evaporated under vacuum. 
To the residue was added 100 µl of redistilled TFA and 
debocing allowed to proceed for 5 minutes. The TFA was then 
removed under vacuum and the dry mixture of deboced 
derivatised insulin redissolved in 50 µl DMSO. The mixture 
was sujected to reverse phase HPLC on a µ - Bondapak C18 
Radial Pak column to separate out the derivatised insulin 
from uncoupled insulin and SASD. 
The gradient solutions were as in 6.2.2 and the gradient 
profile as follows: 
0% B for 10 minutes 
O - 35% B over 5 minutes 
35 - 55% B over 40 minutes 
55 - 100% B over 5 minutes 
The flow rate was 1 ml / minute and the relevant peaks were 
collected as 1 ml fractions. The fractions were lyophilised 
redissolved in a minimum of DMSO and pooled according to 
content. After removal of an aliquot for analysis by acid -
urea PAGE, the remainder was dried under vacuum and stored 
at minus 20°c. 
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6.2.4 The Synthesis of [125I]SASD Derivatised Insulin 
The protocol was identical to that employed in (6.2.3), 
except that carrier - free iodinated SASD was coupled.to the 
diboc insulin. 
6.2.5 The Preparation of Carrier - Free Iodinated SASD 
The iodination of SASD was performed in iodogen tubes 
prepared by aliquoting 1 ml of an iodogen solution (1 mg / 
50 ml chloroform) into Eppendorf vials and allowing the 
chloroform to evaporate. 
To an iodogen tube was added 100 µg SASD in 50 µl DMSO and 
10 µl 125r. Iodination was allowed to proceed for 1 minute, 
after which the sample was subjected to reverse phase HPLC 
(C18 column) to separate (125r)SASD from non - iodinated 
SASD and free 125r. 
The gradient ~olutions were as in 6.2.2 and the gradient 
profile as follows: 
0% B for 10 minutes 
O - 40% B over 5 minutes 
40 - 60% B over 45 minutes 
60 - 100% B over 5 minutes 
The flow rate was 1 ml / minute and the relevant peaks 
collected as 1 ml fractions. The fractions were~ lyophilised, 
redissolved in a minimum of DMSO and pooled . After 
evaporation under vacuum, the samples were stored at -20°c. 
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6.3 Binding, Labelling and Biological Induction studies 
6.3.1 Photoaffinity Labeling of Proteins with fr32p]N3ATP 
The proteins to be labeled were dissolved in 250 µl of 
incubation medium (50 rnM Tris-HCl, pH 9.0; 25 rnM KCl, and 5 
rnM MgC1 2 ) and transferred to acid - cleaned quartz silica 
cuvettes. To these were added 1 µM (r32P]N3ATP (10 Ci / 
mmol) and the samples were then irradiated by means of eight 
10 millisecond flashes of a quartz xenon lamp connected to a 
500 V capacitor discharge system (section 6.4.15.). The 
solutions were removed from the cuvettes and the protein 
precipitated with trichloroacetic acid at a final 
concentration of 10%. The resulting precipitates were 
neutralized and solubilized in sample application buffer. 
The samples were subjected to SOS-PAGE (6.4.7.3.) and the 
resultant band excised and placed in 10 ml of liquid 
scintillation fluid. 
When labelling creatine kinase, 5 rnM creatine was included 
in the incubation medium. 
6.3.2 Photoaffinity Labelling of Membranes with fr32p]N3ATP 
All manipulations prior to photoflashing were performed in 
subdued light. 
Membranes (100 - 250 µg) to be labelled were suspended in 
250 µl of 0,25 M sucrose / TMEN (40 rnM Tris-HCl, pH7.8; 10 
rnM MgCl2; 2 rnM EDTA, and 100 rnM NaCl). These were incubated 
with 1 µM [r32P]N3ATP (50 Ci / mmol) and after an initial 
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incubation period of 5 minutes w~re pelleted and the pellets 
resuspended in fresh incubation medium. The suspensions were 
transferred to acid-cleaned quartz cuvettes and irradiated 
as described in 6.4.15. The suspensions were then 
transferred to 1,5 ml Eppendorf vials and the membranes 
pelleted by centrifugation in a microfuge. The labelled 
membrane pellets were prepared for PAGE and subsequent 
autoradiography as described in section 6.4.7.4. 
Control samples were incubated exactly as described except 
that the samples were not irradiated (- u.v.). 
6.3.3, Phosphorylation by Endogenous Protein Kinases 
Incubations were performed at 22°C in 1,5 ml Eppendorf 
vials. 
Nuclei or membrane fractions (100 - 250 µg) were suspended 
in 250 µl of 0,25 M sucrose / TMEN (see 6.3.2). The 
fractions were then incubated with 5 µM [~32p]ATP (10 Ci / 
mmol) for 5 minutes (unless otherwise stated) and the 
labelling was rapidly terminated by the addition of sodium 
metabisulphite to a final concentration of 50 mM. The 
samples were pelleted by centrifugation in a bench - top 
microfuge and the supernatants removed. 
The phosphorylated nuclei / membranes were then solubilized 
for PAGE and autoradiography. 
6.3.4 In Situ Binding of [125I]ASD-Insulin to H~patoma Cells 
Hepatoma cells (H411E) were grown to confluency (1 x 107 
cells / flask) and starved of insulin the day prior to 
binding studies. The medium was removed from the flasks and 
replaced with 4 ml of binding medium (MEMS, 0.1% BSA, 20 mM 
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Hepes, pH 7.4). To each flask.was added the synthesised 
[125r)ASD-insulin and 100 µM cold insulin in the case of 
displacement studies and the flasks were incubated at 4°C 
for 2 hours in the dark. The incubation medium was then 
removed and the cells were thoroughly washed with cold PBS. 
To the washed cells was added 4 ml of PBS and the flasks 
were irradiated on a transilluminator for 3 minutes. The 
cells were then detached and pelleted. The pellet was 
resuspended in 1 ml of 0.32 M sucrose / TKM and homogenised 
with a hand held homogeniser. The plasma membranes were 
isolated as in 6.1.4, solubilised in SDS sample buffer and 
run on a 10% polyacrylamide gel. Labelled bands were 
visualised by autoradiography (6.4.7.3). 
Labelling studies with Friend cells were performed 
essentially as for the hepatoma cells except that, being 
free - floating, the cells did not require detachment. 
6.3.5 [125I]ASD-Insulin Binding to the Cellular Subfractions 
This protocol was employed for in vitro labelling studies 
using [125r]ASD-insulin and is applicable' for plasma 
' 
membrane, nuclei, nuclear envelope, and chromosomes. 
The fractions (aproximately 200 µg) were suspended in 400 µl 
incubation medium (0.25 M sucrose / TMEN) to which was added 
[125r)ASD-insulin and 100 µM cold insulin in the case of 
displacement studies. The fractions were thus incubated for 
2 hours at 22°C with constant rotation in the dark and then 
pelleted. The pellets were washed three times by 
resuspension and centrifugation and finally resuspended in 
250 µl of incubation mixture. The samples were then 
subjected to ultra violet' radiation for 3 minutes and the 
resultant labelled fractions pelleted. The pellets were 
solubilised in SDS sample application buffer and subjected 
to polyacrylamide gel electrophoresis (6.4.7.3.). Labelled 
bands were visualised by autoradiography. 
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6.3.6 In Vivo Transcription 
In vivo gene induction studies were undertaken on H4IIE 
hepatoma cells which had been starved overnight in serum -
free medium. The induction studies were undertaken by Dr. 
Brenda Stickells. 
Prior to induction studies the medium was decanted and the 
cells refed with serum - free medium containing various 
concentrations of insulin or ASD-insulin. The cells were 
incubated for 180 minutes, after which the medium was 
decanted and the cells detatched with DPBSA. The cells were 
harvested and RNA isolated by the method of Chirgwin et 
al.(1979) using cscl gradient fractionation. 
The isolated RNA was quantitated by measuring OD26onm , 
denatured using formamide and finally cross - linked to 
nylon membrane (Hybond N) by means of u.v. radiation. 
Specific mRNA probes (pyruvate kinase and tyrosine amino 
transferase) were labelled by nick translation and 
hybridised to the bound RNA by the method of Wahl et al. 
(1981). The level of hybridisation was quantitated by means 
of autoradiography and densitometric scans of the· resultant 
autoradiograms. 
6.3.7 Test for Biological Activity of Insulin (Mouse Drop 
Test) 
This test was employed to compare the in vivo effect of the 
synthesised insulin analogue with that of native insulin and 
was performed essentially as described by Thompson (1946). 
The mice were divided into four groups of 20 each and 
maintained in these groupings for the duration of the 
experiment. The mice were starved for 6 hours and maintained 
at 37°C for 1 hour prior to being injected intraperitoneally 
and placed on wire mesh racks inclined at 60° (one rack per 
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group) . This acted a~ an earl~ warning system since 
hypoglycemic mice would slide off and convulse and could all 
be resuscitated by intraperitoneal administration of 0.5 ml 
of 15% glucose. 
The injection protocol was as follows: 
Group 1: native insulin, low dosage (18 mu / 30 g body 
weight). 
Group 2: native insulin, high dosage (36 mu / 30 g body 
weight). 
Group 3: SASD insulin, low dosage (0.8 µg / 30 g body 
weight). 
Group 4: SASD insulin, high dosage (1.6 µg / 30 g body 
weight). 
Two hours after insulin administration, the mice still 
clinging to the rack were counted to determine the efficacy 
of the insulin. 
To improve the statistical significance of t~e assay, 
further experiments were undertaken using intermediate 
dosages (29 mu native insulin, 1.2 µg ASD-insulin) and by 
rotating the insulin formats such that all groups were 
exposed to low and high dosages of native insulin and SASD-
insulin. 
6.4 Analytical Procedures 
6.4.1 DNA Determination 
The method was that of Schneider (1957). Aliquots of the 
samples to be determ~ned were pipetted into acid - cleaned 
bench top centrifuge tubes and inade to 1 ml with distilled 
water. To these were added 1 ml of 20% (v / v) perchloric 
acid, 2 ml of 4% diphenylamine in glacial acetic acid, and 
0,1 ml of aqueous acetaldehyde (0,2 ml / 100 ml). The tubes 
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were vigorously vortexed and incubated at 56°C for 60 
minutes. After this incubation time 1 ml of amyl acetate was 
added and the contents vortexed. The two phases were 
separated by centrifugation and the amyl acetate phase 
removed to determine the absorbance at 578 nm. The 
absorbance of samples and DNA standards were determined in 
triplicate. 
6.4.2 Protein Determination 
The method employed was essentially as described by Lowry et 
al. ( 1951) . 
Reagent A: 2% sodium carbonate in 0,1 N sodium hydroxide. 
Reagent B: 1% copper sulfate 
Reagent C: 2% sodium, potassium tartrate 
Reagent D: reagent A : reagent B : reagent C (100 : 1 : 1) 
Aliquots of samples to be determined were pipetted into acid 
cleaned tubes and made to 1 ml with distilled water. To each 
tube was added 5 ml of reagent D followed by mixing. The 
samples were incubated at 22°C for 10 minutes, after which 
was added 0,5 ml of Folin reagent -(diluted 1 : 2 with 
distilled water). The tubes were shaken and incubated at 
22°c for 30 minutes and the absorbance then measured at 492 
nm. The quantitation of samples and standards was determined 
in triplicate. 
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6.4.3 Protein Determination (Micro - Determination) 
This assay was employed to accurately determine protein 
concentrations in the 1 - 10 µg range and is based on the 
method of Bensadoun and Weinstein {1976). Samples to be 
assayed were placed in 1,5 ml Eppendorf vials and made to 1 
ml with distilled water. To this was added 10 µl of 1,66% 
sodium deoxycholate and the mixture allowed to stand for 15 
minutes, after which was added 333 µl of 24% trichloroacetic 
acid. The vials were thoroughly vortexed and centrifuged at 
x39000g for 30 minutes at 4°C. To the resultant pellets was 
added 1 ml of reagent D (as in 6.4.2) and 0,1 ml of Folin 
reagent (diluted 1: 1 with distilled water). After 75 
minutes the absorbances were measured at 660 nm. Samples and 
standards were assayed in triplicate. 
6.4.4 Km of Hydrolysis of {~32P]N3ATP by {Na+,irf"JATPase 
The experiments were undertaken in subdued light so as to 
avoid photoactivating the N3ATP which could then cross -
link the ATP - binding site of the ATPase. 
0,02 U of (Na+,K+]ATPase {Sigma) in 250 µl incubation medium 
(50 mM Tris-HCl, pH7.4; 25 mM KCl; 5 mM MgCl2; 1 and 30 mM 
NaCl) was incubated with varying amounts of either 
[~32PJN3ATP or (~32PJATP for 10 minutes at 22°C. The rates 
of hydrolysis of ATP or the analogue were determined by the 
activated charcoal method (6.4.11.). The data was then 
subjected to Lineweaver - Burk analysis to determine the Km 
value. 
V was defined as: 
nmol of 32pi released / 0,02 U [Na+,K+]ATPase / 10 minutes. 
Competition studies were performed by the addition of 20 mM 
cold ATP to the incubation medium. The mode of inhibition 
was determined from Lineweaver - Burk plots. 
118 
6.4.5 Identification of Glycosylated Proteins 
Nuclei and the various membrane fractions were subjected to 
sos - PAGE and the resultant gels blotted onto 
nitrocellulose. These blots were then incubated with 3% BSA 
/ PBS (phosphate - buffered saline) for 16 hours in order 
to avoid non - specific binding by 1251. This was followed 
by 2 washes each in PBS, PBS plus 0,1% Triton-XlOO, and 
finally PBS. Each wash was 30 minutes in duration and was 
performed with constant agitation. 
The treated blots were then incubated with 1251 - labelled 
lectins in a minimum of PBS for 120 minutes and then 
subjected to the same wash cycle as described above, 
followed by autoradiography. 
6.4.6 Iodination of Proteins and Lectins 
The samples were dissolved in 500 µl of PBS in a 1,5 ml 
Eppendorf vial and to this was added 2 µl of 1251 (specific 
activity 3000 Ci / mM. Two lodo -Beads (Pierce) were then 
added and the solution incubated for 15 minutes. The 
iodinated samples were separated from unbound 1251 by 
dialysis on a 0.025 µm, type VS membrane (Millipore)· 
floating on 200 ml of PBS. The dialysis was repeated twice 
by which stage >99% of unbound 1251 was removed. The 
iodinated samples were then stored at -20°c. 
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6.4.7 SDS - Polyacrylamide Gel Electrophoresis 
6.4.7.1 Two Dimensional Polyacrylamide Gel Electrophoresis 
Two dimensional PAGE was performed essentially as described 
by O'Farrell (1975). 
Solutions 
First dimension gel 
Solution A 28,38% acrylamide 
1,62% NN - methylenebisacrylamide 
Solution B 10% (v / v) Nonidet P-40 
First dimension tray buffers 
IEF top tray 0,02 M sodium hydroxide 
IEF bottom tray 0,01 M phosphoric acid 
First dimension gel overlay solution 
8 M urea 
First dimension sample overlay solution 
9 M urea 
1% ampholytes (3 / 10 range) 
First dimension application buffer 
. 
Second dimension gel 
solution A 
9,5 M urea 
2% (v / v) Nonidet-P40 
5% (v / v) B - mercaptoethanol 
2% ampholytes (3 / 10 range) 
29,2% acrylamide 
0,8% NN-methylenebisacrylamide 
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Solution B 
Solution C 
1,5 M Tris-HCl, pH 8,8 
0,4% sos 
0,5 M Tris-HCl, pH 6,8 
0,4% sos 
Second dimension tray buffers 
0,025 M Tris 
0,192 M glycine 
0,1% sos 
Second dimension application buff er 
Gel Preparation 
First dimension gels 
10% (w / v)glycerol 
0,0625 M Tris-HCl, pH 6,8 
2,3% sos 
5% (v / v) B - mercaptoethanol 
The gel solution was prepared as follows: 
2,75 g urea 
665 µl solution A 
1 ml solution B 
250 µl ampholytes (3 / 10 range) 
990 µl distilled water 
To this solution was added 10 µl of 10% ammonium persulphate 
and 7 µl of TEMED. After thorough mixing the gel solution 
was drawn up into a 5 ml syringe to which was attached a 12 
cm piece of flexible tubing. This was used to fill four 10 
cm long - glass tubes (internal diameter 2 mm) which were 
stoppered at one end with paraf ilm. After ensuring that no 
air bubbles were introduced, the tube gels were overlayered 
with the gel overlay solution and allowed to set. The 
overlay solution was replaced 120 minutes later with first 
dimension application buffer. 
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Second dimension gels 
To make 140 ml of a 10% running gel: 
47 ml solution A 
35 ml solution B 
58 ml distilled water 
1 ml 10% (w / v) ammonium persulphate 
150 µl TEMED 
To make 40 ml of stacking gel: 
6 ml solution A 
10 ml solution C 
24 ml distilled water 
Agarose - sealed plates with 1,5 mm spacers were filled to 
within 2 cm of the top with the running gel solution and 
overlayered with 1 ml of isopropanol. 
When the gel had polymerised the isopropanol was poured off 
and the gel topped with the stacking gel. 
Running The Gels 
First dimension 
Isoelectric Focussing CIEF) 
The paraf ilm was removed and the tubes mounted through the 
top chamber grommets such that the bottom of each tube was 
immersed in the bottom chamber. To the bottom chamber 
(positive polarity) was added 0,01 M phosphoric acid and to 
the top chamber (negative polarity) 0,02 N sodium hydroxide. 
The first dimension application buffer was removed from the 
top of the tube gels and replaced with 50 µl fresh buffer. 
The tubes were then topped up with sample overlay buffer. 
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The gels were then su~jected to a pre-- electrophoretic 
cycle as follows: 
200 V for 15 minutes 
300 V for 30 minutes 
400 V for 30 minutes 
The top tray buff er was decanted and all buffers removed 
from the top of the tube gels. The sample solubilised in 
first dimension application buffer was then applied to the 
gels and -overlayed wit~ 30 µl sample overlay solution. The 
top tray was then refilled with tray buffer and the gel run 
at 400 V for 16 hours. 
Non - Equilibrium pH Gradient Electrophoresis CNEPHGE) 
The tubes were mounted in the electrophoresis apparatus as 
described for IEF gels except that the tray ~oiarities were 
reversed i.e.the top tray was positive and contained 0,01 M 
phosphoric acid. The gels were not pre-electrophoresed and 
the gels were run at 400 V for 480 minutes. 
Second dimension 
The first dimension ~els were extruded on top of the second 
dimension gels and immediately bonded with a hot solution of 
1% agarose dissolved in second dimension application buffer. 
. ': . -
To the bottom chamber was added tray buff er and to the top 
tray was added tray buffer containing 2% sos (cf. 0,1% for 
normal tray buffer). After electrophoresis at 150_V for 30 
minutes the top tray was emptied and.refilled ·with normal 
buffer and the gels subjected to electrophoresis at 150 V 
for 12 hours. 
The resultant gels were stained, photographed and subjected 
to autoradiography as required. 
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6.4.7.4 Sample Preparation for one Dimensional SDS PAGE 
Pelleted samples were dissolved in 70 µl of second dimension 
application buffer containing dextran blue as tracker dye, 
and boiled for 10 minutes. The samples were then centrifuged 
in a bench top microfuge to pellet insol~ble material and 
the supernatants applied to the wells of the gels. 
6.4.B Acid Urea Polyacrylamide Gel Electrophoresis 
Acid urea polyacrylamide gel electrophoresis was performed 
essentially as described by Panyim and Chalkley (1969). 
Solutions 
Solution A 
Solution B 
Solution C: 
Tray buffer; 
60% acrylamide 
0,4% NN-methylenebisacrylamide 
43,2% acetic acid 
4% TEMED 
o,a mM Tris 
0,1% riboflavin 
0,9 M acetic acid 
Sample application buffer; 50% (v / v) acetic acid 
1 µg / ml pyronine Y 
Gel preparation 
The gel solution was prepared by dissolving 14,4 g of urea 
(5 M) in 12 ml of solution A, 6 ml of solution B, and 
sufficient distilled water to make up the final volume to 48 
ml. On addition of 100 µl of solution c , the solution was 
cast as 1,5 mm slabs in agarose - sealed gel plates 
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Running the gels 
Samples were dissolved in 70 µl of sample application buffer 
and applied to the gels. 
The samples were electrophoresed at a constant current of 20 
mA for 240 minutes. The migration was from positive to 
negative. 
The resolved gel was then stained, photographed, and 
autoradiographed as required. 
6.4.9 Staining of Gels 
Coomassie stain 
The gels were stained for 180 minutes in staining solution 
(0,1% Coomassie brilliant blue; 50% meth~nol; and 10% acetic 
acid) with constant agitation. The stained protein bands 
were then visualised by destaining in destaining solution 
(25% ethanol, 7% acetic acid). 
Silver staining 
Silver staining ~as performed as described by Ansorg (1982) 
All steps were performed at 22°C with agitation. 
A: 
B: 
Developer: 
50% methanol, 12% TCA, 2% copper chloride 
10% ethanol, 5% acetic acid 
0,01% formaldehyde, 2% potassium 
carbonate 
The gel was immersed sequentially into the following 
solutions: A for 30 minutes, B for 10 minutes, 0,01% 
potassium permanganate for 10 minutes, A for 10 minutes, 10% 
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ethanol for 10 minutes, water.for 10 minutes, 0,1% silver 
nitrate for 10 minutes, water for 30 seconds, 10% potassium 
carbonate for 1 minute, and finally developer until the 
bands were visualised. 
6.4.10 Streptozotocin - Induced Hyperglycemia in Rats 
Rats were injected intrapertoneally with streptozotocin at a 
dosage of 10 mg / 100 g body weight. 
Blood glucose levels were monitored daily with the aid of 
the Haemo - Glukotest strips (Boehringer) and the rats were 
deemed to be hyperglycemic when the glucose level rose above 
300 mg / 100 ml. At this stage the rats displayed agitated 
behaviour and urinated excessively. The rats were sacrificed 
by cervical dislocation and exsanguination. 
6.4.11 Charcoal Assay 
To 250 µl of 50 mM KH 2Po4 was added 1 µl of the sample and 
the mixture thoroughly mixed. A 25 µl aliquot was removed 
and added to 10 ml of liquid scintillation fluid for 
counting (A). To the remainder of the solution was added 50 
mg of finely ground activated charcoal and the mixture was 
thoroughly vortexed. After pelleting the charcoal by 
centrifugation for 1 minute, 25 µl of the supernatant was 
removed and added to 10 ml of liquid scintillation fluid 
(B) • 
% incorporation = B / A x· 100 
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6.4.12 Photography and Autoradiography 
Destained gels were placed on an illuminated box and 
photographed using Kodak Technical Pan and a red filter . 
. 
When photographing silver stained gels no filter was used. 
The films were developed according to the manufacturer's 
specifications. 
Gels were flat - dried by heating on an evacuated heating 
tray and placed in X - ray cassettes to expose Cronex 4 X-
ray film. 
6.4.13 Thin Layer Chromatography 
For monitoring NJATP reactions, samples were applied to PEIE 
- cellulose plates and run in 1,2 M lithium chloride. 
For monitoring SASD reactions, samples were applied to 
silica plates and run in a benzene : amyl alcohol : 
chloroform: acetic acid solvent system (1: 1 : 1: 0,1). 
Plates were dried, covered in plastic film and 
autoradiographed. 
6.4.14 Tissue culture 
Friend cells were grown in suspension in RPMI 1640 with 10% 
fetal calf serum at 37°C (humidity 95%;, C02 5%). 
Hepatoma cells (H4IIE) were cultured in EMEM cQntaining 10% 
fetal calf serum at 37°C '(humidity 95%, co2 5%). At 80% 
confluency, the cells were detached by washing for 3 minutes 
with DPBSA and replated. 
HTC hepatoma cells were cultured in Spinner culture with 
Jokliks EMEM (Earles Modification of Eagles Medium) for 
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suspension culture, containing 0,005 M tricine. The flasks 
were constantly rotated on a Coulter mixer. 
Prior to use in hormonal studies or subcellular 
fractionation, the cells were starved by refeeding with 
fetal calf serum - free medium for 24 hours. 
6.4.15 Construction of the Ultra Violet Photoflash Unit 
The photof lash unit is a capacitor discharge system, 
consisting of 4 100 V capacitors in series which were 
connected to a quartz - silica xenon lamp (Heimann GmbH, 
Wiesbaden - Dotzheim. Type EG 9902, 500V). The design is 
based on that described by Frimmer and Ziegler (1986). This 
system was capable of discharging a broad spectrum, high 
intensity flash (500 V) in 10 milliseconds. 
The xenon tube is attached to the under - side of the 
sliding lid of the light - proof housing. Samples (either 
culture dishes or quartz silica cuvettes) are placed on 
specially constructed adaptors at the base of the box and 
the lid then slid into position. This configuration ensures 
that all samples are equidistant from the overhead lamp. 
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Appendix 
The Use of carrier - Fr~e s-Azidoadenosine 5'[~32p] 
Triphosphate to Investigate the Putative Intrinsic Protein 
Kinase Activity of the Purified Glucocorticoid Hormone 
Receptor complex. 
A.1 Introduction 
Work in this laboratory has also focussed on the isolation 
and characterisation of the rat liver glucocorticoid hormone 
receptor complex. Dr. Hapgood has succeeded in purifying the 
receptor complex 9000 fold (Hapgood & von Holt, 1987) and an 
investigation of the protein kinase activity of the 
preparation using the synthesised azido-ATP (N3ATP) was 
undertaken (Hapgood et al., 1986). This investigation was of 
interest owing to the contradictory evidence on the putative 
protein kinase activity of the glucocorticoid steroid 
receptor. 
The progesterone receptor has been demonstrated to possess 
intrinsic kinase activity (Garcia et al., 1983) and to be 
phosphorylated by cAMP - dependent protein kinases (Weigel 
et al., 1981). The estrogen receptor is tyrosine 
phosphorylated (Migliaccio et al., 1984) but no evidence for 
intrinsic kinase activity was available. 
Protein kinase activity in glucocorticoid receptor 
preparations had been reported (Kurl & Jacob, 1984; Singh & 
Moudgil, 1984; Miller-Diener et al., 1985) but the authors 
provided no direct evidence of receptor autokinase activity. 
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Pigure 1 Characterisation of DEAE - sephacel Purified GHRC. 
comparison with control Mock Isolations. 
The untransformed molybdate - stabilised GHRC was purified 
as described by Hapgood and von Holt (1987) . Briefly, rat 
liver cytosol was subjected to phosphocellulose 
chromatography as described by Govindan and Gronemeyer 
(1984). The phosphocellulose flow - through was then 
incubated with the affinity matrix (synthesised by coupling 
the the 17B-carboxylic acid of dexamethasone to Affi-Gel 102 
(Bio-Rad) via the N-hydroxybenzotriazole ester of 
dexamethasone). After thorough washing of the matrix, the 
receptor was eluted by incubation with 2 µM of tritiated 
triamcinolone acetamide. ({3H]TA) (5 Ci / mmol) for 16 hours. 
The resultant eluate was then subjected to DEAE-Sephacel 
chromatography and the untransformed GHRC eluted in the 
presence or.absence of 10 mM molybdate with either a o - 500 
mM sodium chloride gradient in buffer A (10 mM Tris-HCl, pH 
7.4, 1 mM EDTA, 5 mM 8-mercaptoethanol, and 10% glycerol), 
or a 50 - 500 mM potassium phosphate gradient in buffer B 
(50 mM potassium phosphate, 1 mM EDTA, 5 mM 8-
mercaptoethanol, and 10% glycerol, pH 7.0). 
Control mock isolations were performed by incubation of 
cytosol with the affinity matrix in the presence of 4 µM 
unlabelled dexamethasone. 
A: {3HJTA elution profile of experiment (dotted line) and 
mock (dashed line) isolations. The preparations were eluted 
with a 50 - 500 mM potassium phosphate gradient in buffer B. 
B: SDS - PAGE of individual fractions of the eluate of the 
experimental isolation. 
C and D: anti - glucocorticoid receptor polyclonal antibody 
binding pattern of individual fractions for experimental (C) 
and mock control (D) isolations. 
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All that could be concluded was that.the glucocorticoid 
receptor was a substrate for protein kinases. 
This chapter summarises the published results (Hapgood et 
al., 1986) into the investigation of the kinase activity 
associated with the glucocorticoid receptor preparations 
under varying conditions of receptor steroid - binding 
activity and transformation state. 
A.2 Results 
The glucocorticoid receptor complex (GHRC) was isolated as 
described by Hapgood and von Holt (1987), and a typical 
final elution profile from DEAE - Sephacel is demonstrated 
in figure 1. The receptor elutes as a 92 kDa steroid -
binding protein at 0.25 M potassium phosphate (figure lA), 
and its identity confirmed by anti - receptor antibodies 
(figure lC). 
Incubation of GHRC preparations with [132P]ATP after elution 
from DEAE - Sephacel in the absence (figure 2A) or presence 
(figure 2B) of molybdate, resulted in the phosphorylation of 
a number of proteins. The kinase activity is Mg2+ -
dependent (figure 2B, lane 6). 
Of particular interest is the phosphorylation of proteins 
with molecular weight of approximately 90 kDa (figures 2A & 
B), although these proteins are phosphorylated to a higher 
degree in the GHRC preparation eluted in the presence of 
molybdate (figure 2B). This difference in labelling was 
shown not to be due to the presence or absence of molybdate, 
but rather to the different gradients used to elute the two 
GHRC preparations, since the phosphorylation profiles of 
receptor preparations eluted from the DEAE - Sephacel in 
buff er 2 (minus molybdate) were identical to those in figure 
2B. The phosphorylation profile of the receptor preparations 
after ammonium sulfate precipitation was also investigated 
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Figure 2 Protein Kinase Activity of DEAE - Sephacel Purified 
GHRC. 
GHRC eluted from DEAE Sephacel in buffer B minus molybdate 
(figure 2A) or buffer A plus molybdate (figure 2B) was 
diluted to a final concentration of 1 µg / ml and incubated 
with [~32P]ATP in the presence of 5 mM magnesium or calcium. 
Coomassie stain: A, lane 2 and B, lanes 2 - 4. 
Autoradiograms, 2 days exposure: A, lane 3 and B, lanes 5 -
7. 
Autoradiograms, 10 days exposure: A, lane 4 and B, lanes 8 -
10. 
Standards lane: A, lane 1 and B, lane 1. 
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Figure 3 Protein Kinase Activity of DEAE - Sephacel Purified 
GHRC After (NH4 ) 2so4 Precipitation. 
GHRC eluted from DEAE - Sephacel in buffer A minus molybdate 
(A, lanes 2 and 3), buffer B minus molybdate (A, lanes 4 and 
5), or buffer A plus molybdate (B, lanes 2 - 5) was 
precipitated with ammonium sulfate. The precipitate was 
resuspended in buffer A containing 50 mM sodium chloride and 
5 mM magnesium chloride and of this, 0.5 µg of GHRC 
incubated with [~32P]ATP under varying conditions of 
molybdate and steroid. 
Coomassie: A, lanes 2 - 5 and B, lanes 2 - 5. 
Autoradiograms: A, lanes 6 - 9 and B, lanes 6 - 9. 
Standards lane: A, lane 1 and B, lane 1. 
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(figure 3). The 90 - 92 kDa fraction is again 
phosphorylated, but to a higher degree than is the case for 
non - precipitated receptor preparation (figure 2). The 
phosphorylation pattern is unaffected by molybdate or excess 
steroid (figure 3), although the overall phosphorylation 
profile is different to that of non - precipitated 
preparations. This probably reflects a selective 
precipitation of protein kinases. 
These results demonstrate that the GHRC preparations have 
protein kinase activity and the fact that this activity is 
independent of molybdate, steroid - binding activity or 
transformation state, indicates that the GHRC receptor may 
not be responsible for the phosphorylation. However, the 
possibility that the receptor is an autokinase, could not be 
ruled out. 
In order to positively identify any ATP - binding proteins 
(and thus potential protein kinases), the receptor 
preparations were incubated with [~32P]N3ATP which was 
synthesised according to the method of Sabbatini and von 
Holt (1987). Incubation of (NH4)2S04 - precipitated receptor 
preparations with [~32P]N3ATP and subsequent photoactivation 
identified a single N3ATP - binding protein (48 kDa) (figure 
4). The possibility that the receptor may be an autokinase 
but is somehow inhibited by the photoactivating conditions 
was discounted by the fact that the phosphorylation pattern 
and intensity during photoactivation was identical to that 
in figure 3 (Hapgood et al., 1986). These results show that 
the receptor does not bind ATP, and thus cannot possess 
kinase activity. 
For further characterisation, fractions for both experiment 
and mock isolations, eluting close to the receptor in DEAE -
Sephacel, were investigated for protein kinase activity 
(figure 5). The phosphorylation pattern in figure 5B 
demonstrates that it is independent of receptor presence 
since the pattern is identical for both experiment and mock 
isolations, as is the N3ATP labelling pattern (figure 5C). 
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Pigur• 4 [~32PJN3ATP Photoaff inity Labellinq of a Contaminant Protein Kinase in Purified (NB4) 2so4 Precipitated GBRC Preparations. 
Precipitated GHRC was resuspended (0.5 µg 200 µl) in 
buffer A containing 50 mH sodium chloride, 5 mH magnesium 
chloride, and 1 µH unlabelled triamcinolone acetonide and 
incubated with carrier - free {~32PJN3ATP. Incubations in 
the presence of 1 mH cold ATP (lanes 1 and 2) or 1 µH 
unlabelled NJATP (lanes 5 and 6) were also performed. 
Lanes 1,3,and 5: incubations in the absence of ultraviolet 
light. 
The autoradiogram was exposed for 2 days. 
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Figure s Protein Kinase contaminant in DEAE - Sephacel 
Purified GHRC. 
Protein kinase and [y32PJN3ATP binding activity in :fractions 
16, 22, and 27 o:f the DEAE - Sephacel eluate (buffer B minus 
molybdate) as defined in figure 1.: Three equal volumes of 
each of fractions 16, 22, and 27 for experimental (E) and 
control (C) isolations were diluted to 600 µl to give a 
final GHRC concentration of 1 µg / 600 µl of GHRC for 
fraction22 of the experimental isolation. Unlabelled 
triamcinolone acetonide (1 µM) and MgC1 2 (5 mM) were added 
to each. 
A: Coomassie pattern. 
B: autoradiogram after incubation with [y32p]ATP for 30 
minutes at 20 't:. 
C: aliquots (2 x 600 µl)of each fraction were heat 
transformed by incubation for 30 minutes at 20 't:. Six 
hundred microliters of each was then incubated for 15 
minutes at 20 't: in the presence of [y32PJN3ATP either in the 
presence or absence of ultraviolet light. In the absence of 
uv, samples analysed as for panel C showed no detectable 
labelled bands (data not shown) • 
Exposure of the gel for 5 days (as oppo.sed to the 24 hours 
for panel C) did not reveal labelling of proteins in the 90-
92 kDa region. However, a.55 kDa band became visible, 
coinciding with the major phosphorylated band in panel B. 
This probably indicates that the N3ATP is being utilised by 
a protein kinase to phospporylate the 55 kDa protein. 
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It is the fractions containing the 48 kDa ATP - binding 
protein {Cl6 and E16) that are most actively phosphorylated. 
In the presence of ca2+, the 48 kDa protein binds ATP with a 
much lower affinity {data not shown) . 
A.3 Discussion 
These results demonstrate that neither the GHRC nor the 90 -
92 kDa non - steroid binding protein associated with the 
molybdate - stabilised GHRC is a Mg2+ - dependent protein 
kinase. Rather, a 48 kDa protein kinase co-isolates with the 
receptor. This kinase phosphorylates a number of 
contaminating proteins and probably the receptor itself. The 
phosphorylation of the 90 - 92 kDa protein appears to be 
unrelated to the presence of molybdate or the steroid -
binding properties of the receptor. 
The presence of ~ contaminating protein kinase could account 
for the conflicting reports on the putative kinase activity 
of the GHRC, especially if the recptor preparations of the 
various authors contained differing amounts of the 
contaminant. Our findings that the GHRC is not an autokinase 
is in agreement with previous findings {Sanchez & Pratt, 
1986). 
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